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Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator 
protein (CFTR) cause cystic fibrosis (CF), the most common life-shortening genetic 
disease among Caucasians. Although general features of the structure of CFTR have been 
predicted from homology models, the conformational changes that result in channel 
opening and closing have yet to be resolved. We created new closed- and open-state 
homology models of CFTR, and performed targeted molecular dynamics simulations of 
the conformational transitions in a channel opening event. The simulations predict a 
conformational wave that starts at the nucleotide binding domains and ends with the 
formation of an open conduction pathway. Experimentally confirmed changes in side-
chain interactions are observed in all major domains of the protein. We also identified 
unique-to-CFTR substitutions that may have led to channel activity in CFTR. Molecular 
modeling and simulations are used to compare the effects of these substitutions against a 
canonical ABC transporter, and suggest that gain of channel function in CFTR may have 
risen from loss of ATPase function at its NBDs. The models and simulation add to our 







The ABC transporter superfamily is a large and ancient family of membrane proteins, 
found in all phyla [1]. Members of the ABC superfamily catalyze the membrane 
transport, in an ATP-dependent manner, of a wide variety of substrates ranging from 
small inorganic ions and metabolites to large hydrophobic drugs and polypeptides. At a 
minimum, all ABC transporters have four domains: two membrane spanning domains 
(MSDs) consisting of transmembrane alpha helices (TMs) embedded in the lipid bilayer, 
and two nucleotide binding domains (NBDs) located in the cytoplasm [2]. A large 
number of studies indicate that the binding and hydrolysis of ATP at the NBDs leads to 
changes in the conformation of the membrane domains [3]. The binding of ATP leads to 
dimerization of the NBDs, which is thought to initiate a conformational cascade that is 
transmitted to the membrane-spanning domains via the intracellular loops (ICLs) that 
emerge from the cytoplasmic ends of the TMs. This results in the MSDs alternating 
between outward-facing and inward-facing states. This “ATP switch” concept has been 
supported by recently published crystal structures of the nucleotide-bound bacterial ABC 
exporter Sav1866 [4], P-glycoprotein (P-gp) (from M. musculus [5] and C. elegans [6]) 
and the bacterial exporter TM287/288 [7] in the nucleotide-free inward-facing states, and 
liganded and unliganded states of the MsbA lipid transporter [8]. Despite their ubiquity, 
however, the precise mechanisms by which ATP binding and hydrolysis and NBD 
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dimerization lead to conformation changes in the remaining domains of these ABC 
transporters are poorly understood.  
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 
Cystic fibrosis (CF) — the most common lethal genetic disease among Caucasians   — is 
caused by mutations in the gene that encodes cystic fibrosis transmembrane conductance 
regulator (CFTR) [9,10], a large transmembrane protein belonging to the ABC 
transporter superfamily [11,12]. This ATP-gated chloride ion channel plays a central role 
in ion transport and water movement across epithelia such as those that line the airways 
and intestinal tracts [13-15]. Loss of CFTR function leads to the impaired mucociliary 
clearance and consequent chronic airway infection seen in CF patients [16], whereas 
excessive enterotoxin-mediated CFTR activation can result in secretory diarrhea [17]. 
Characteristic of its ABC transporter heritage, CFTR has a domain architecture (Figure 
1.1) comprising two membrane-spanning domains (MSD1 and MSD2), each containing 
six transmembrane α-helices (enumerated TM1 through TM12); and two cytosolic 
nucleotide binding domains (NBD1 and NBD2) that have ATPase activity [2]. Unlike 
any other ABC protein, however, CFTR also has a large regulatory (R) domain, situated 
between NBD1 and MSD2 in its sequence. The R domain has multiple phosphorylation 
sites which, along with ATP binding and hydrolysis at the NBDs, play a major role in the 
regulation of channel activity [18,19].  
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Figure 1.1: Domain topology of CFTR 
 
While over 1,500 disease-causing mutations of the CFTR gene are known (Cystic 
Fibrosis Mutation Database, http://www.genet.sickkids.on.ca/), over 90% of cystic 
fibrosis cases are cause by the deletion of a phenylalanine residue at position 508 — 
ΔF508 [20]. This mutation is thought to hamper CFTR folding and signal transduction by 
destabilizing the interface between the NBD1 and ICL4 domains, although accurate 
models of the interactions of this residue in the native state do not exist.  
CFTR: Degraded Transporter Turned Ion Channel 
Most ABC transporters mediate active membrane transport through an alternating access 
mechanism, but CFTR is unique in this group as the only member known to function as 
an ion channel, primarily for chloride ions [14]. The structural basis for this important 
difference in function, however, is not yet known. Studies have also investigated the role 
that CFTR plays in transporting glutathione, the most prominent regulator of redox status 
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in the lung [21]. In the lungs of CF patients, glutathione concentration in the airway 
surface liquid is drastically reduced, which contributes to oxidative stress. CFTR 
therefore seems to be a dual-function protein that bears channel activity, but also appears 
to retain residual transporter activity. In fact, CFTR is thought to have evolved from an 
alternating access transporter that was somehow degraded to allow the formation of a 
continuous pore for ion conduction and for NBD-initiated conformation changes to gate 
this pore [22,23]. 
In most ABC transporters, ATP binding at the two NBDs results in the formation of a 
head-to-tail NBD dimer that drives a conformational change in the whole protein which 
enables membrane transport [3].  
 
 
Figure 1.2: ATP-regulated alternating access in atypical ABC transporter 
 
In a typical ABC exporter transport cycle (Figure 1.2), for instance, the intracellular 
substrate to be pumped out first binds to a pocket in the membrane-spanning domain of 
the protein in its “inward-facing” conformation (A). Then, the binding of cytosolic ATP 
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to the ATP binding sites (ABSs) results in the formation of a dimer between the NBDs 
(B, C). This initiates a chain of conformational changes that results in the switching of 
the protein to an “outward-facing conformation” (D). The substrate is then free to diffuse 
into the periplasm (this may be aided by a concomitant change in the structure of the 
binding pocket that leads to a lower affinity interaction between the substrate and the 
protein in the outward-facing state). In addition to being able to bind ATP molecules, the 
NBDs of most ABC transporters are also capable of catalyzing the hydrolysis of bound 
ATP to ADP when in dimer formation [24] (E). The energy released from ATP 
hydrolysis initiates a second chain of events that eventually leads to dissociation of the 
two nucleotide binding domains. This conformation change reverses the effect of 
dimerization, reverting the molecule to the original “inward-facing” state. Release of the 
hydrolysis by-products (ADP + Pi) allows the cycle to start anew. Unlike other ABC 
proteins, however, CFTR shows significant disparity in both the sequence and function of 
the two NBDs. Whereas the site in NBD2 is capable of both ATP binding and hydrolysis, 
the equivalent site in NBD1 is thought to have poor hydrolytic activity, engaging in 
stable interactions that retain the nucleotide at the binding site for long periods [25]. 
Conformational transitions in CFTR are therefore thought to involve at least four distinct 
states (Figure 1.3):  
1) C0: an apo closed-channel state where both nucleotide-binding sites are empty 
and the NBDs are completely dissociated;  
2) C1: a closed-channel state where the NBD1 site is occupied and the NBDs are 
partially dimerized;  
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3) C2: a strained transition state where the NBDs are fully dimerized but the channel 
is still closed to conduction; and  
4) O: an open-channel state with tightly dimerized NBDs in which both of the 
binding sites contain ATP. 
 
Figure 1.3: States in CFTR’s gating cycle 
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While high-resolution X-ray crystal structures of the nucleotide binding domains exist 
[26-28], structural information on the MSDs and the unique-to-CFTR R domain has been 
scarce, with only low-resolution NMR and cryo-EM electron density maps currently 
available [29,30]. However, since ATP binding and tight NBD dimerization are necessary 
for channel opening [31], it has been hypothesized that CFTR evolved from a degraded 
ABC exporter whose ATP-bound outward-facing state corresponds to the open CFTR 
channel [23]. Due to the low ATP turnover rate at NBD1, the dominant closed channel 
conformation is thought to be the partial-dimer C1 state, although the fully dissociated C0 
state is also likely to be closed to ion conduction. 
Translational Impact 
There are nearly 50 known ABC transporters in humans and 13 genetic diseases 
associated with defects in them [32]. Furthermore, several ABC transporters capable of 
transporting large amphipathic compounds are thought to contribute to the resistance of 
cancer cells to chemotherapy. Understanding the structural basis for the pump cycle of 
these transporters can aid in the design of drugs that can correct defects in mutants, or of 
chemotherapeutic agents that can circumvent or suppress ABC transporter-related multi-
drug resistance.  
In addition, understanding the dynamic structure of the pore in CFTR in particular is 
important for several reasons. First, this channel is clinically relevant to the pathogenesis 
of CF, the most common lethal autosomal recessive disease among Caucasians, affecting 
more than 30,000 Americans and many more worldwide. The development of 
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pharmacological modulators for CF requires a better understanding of the function of the 
normal channel. Second, CFTR is also involved in two other diseases of note: polycystic 
kidney disease (the fourth leading cause of end-stage renal disease in America) and 
secretory diarrhea including cholera (a worldwide health problem). Understanding the 
dynamic structure of the pore may lead to the design of clinically useful inhibitors to treat 
the rampant secretion associated with these conditions. Understanding the nature of the 
stable open state will aid in the rational design of drugs that can lock mutant CFTR 
channels open in the plasma membranes of CF airway epithelial cells, leading to 
increased chloride secretion and amelioration of disease. residues that may be crucial to 
the maintenance of the open pore and for ion conduction. Finally, because computational 
models of CFTR can be validated experimentally with very high resolution using 
electrophysiology techniques that are unavailable for the study of other ABC transporters, 
we may be able to extrapolate the observations in CFTR to understanding how the 
substrate binding pockets of clinically-relevant ABC transporters change structure during 
the pump cycle. 
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HOMOLOGY MODELS OF CFTR IN THE OPEN & CLOSED 
CHANNEL STATES 
Abstract 
We created a homology model of the open-channel state of CFTR, incorporating a 
combination of secondary structure predictions, hydropathy analysis, and pore 
accessibility indicators in the template-target alignment. Soft semi-harmonic restraints 
were added between particular residues in order to ensure that established salt bridges 
and distance constraints derived from disulfide crosslinking experiments in CFTR double 
cysteine mutants were satisfied. The established R352-D993 and R347-D924 salt bridge 
residue pairs are observed in our model, and a review of the surface accessibility status of 
predicted pore-lining residues in the critical TM6 and TM12 helices reveals that our 
model has more of these residues exposed to the aqueous conduction pore than previous 
open-state models. Close inspection of the pore structure reveals a narrow region, 
centered upon S341 in TM6 and T1134 in TM12, which separates the transmembrane 
pore into an inner and outer vestibule, consistent with the functional role of S341 in anion 
selectivity in CFTR. In addition, we also created a model of the closed state of CFTR 
using the inward-facing X-ray crystal structure of murine P-glycoprotein (P-gp) as a 
template, following a similar procedure to that used in generating the open state. We 
demonstrate the predictive power of our open and closed-state models by examination of 
the state-dependent accessibility of the arginine at position 334. 
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Introduction 
Understanding structure-function relationships in CFTR will aid in the development of 
therapeutic treatments for the underlying cause of cystic fibrosis. To aid in this effort, X-
ray crystal structures of the soluble first nucleotide binding domain (NBD1) [1], and a 
low resolution structure of the full protein from 2D crystals [2] have been published. 
However, despite sustained effort by numerous groups over several years, the structure of 
the rest of the protein has not yet been determined at adequate resolution to allow strong 
inference of structure-function relationships. The lack of a reliable molecular structure 
has hampered efforts to design new therapies that correct the basic defect in CF, and to 
understand the mechanism by which existing CFTR corrector drugs operate. 
Furthermore, interpretation of experimental data (e.g. from electrophysiological studies) 
is often challenging in the absence of structural framework in which to contextualize 
these results. 
Homology modeling — often termed comparative modeling — has been explored in the 
past to propose candidate structural models of the full CFTR protein. In the following, we 
will briefly review the central ideas of homology modeling, the state-of-the-art in 
modeling of CFTR and related ABC transporter proteins, and describe the need for 
improved structural models of CFTR. 
Homology Modeling 
Homology modeling is a theoretical method (as opposed to an experimental method, such 
as X-ray crystallography or NMR) for the prediction of protein structure. However, 
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unlike purely physical theoretical approaches — which usually rely on modeling the 
interaction between the atoms of a protein using a variety molecular mechanics methods 
— homology modeling leverages knowledge of the experimentally determined structures 
of related template proteins to predict the conformation of the target protein of interest. 
The key observation that allows this method to be feasible is that small changes in the 
sequence of protein usually result in small changes in structure; in fact, structural 
homology is found to be more strongly preserved than sequence homology [3]. It stands 
to reason, therefore, that if an experimental structure related to a protein of interest in 
amino acid sequence can be found, it may serve as a useful starting point for the creation 
of a model structure of the target protein. 
Many homology modeling protocols have been proposed and implemented, but the 
method proposed by Sali & Blundell [4] has received the most widespread acceptance. 
This is partly due to its relative ease of use for novices, and partly due to the powerful 
flexibility it affords to more experienced practitioners. In their method, one begins by 
supplying a superposition of the amino acid sequences of the template and target proteins. 
This alignment may be generated from a pairwise comparison of the sequences, 
optimizing against a suitable set of amino acid substitution penalties (e.g. as is usually 
done with a BLAST search), or one may employ additional indicators of good fit in more 
advanced methods, some of which will be discussed in the Methods section of this 
chapter. The modeling algorithm then generates, based on the sequence alignment, a 
network of spatial restraints (expressed as probability density functions) for a number of 
structural features expected in the target, based on the template. This includes, among 
other features, C-α–C-α distances, main-chain N–O distances, and main-chain and side-
 15 
chain dihedral angles. A 3D model that conforms to the input restraints as much as 
possible is then generated and optimized using a combination of conjugate gradient 
energy minimization and molecular-dynamics-based simulated annealing. One useful 
feature of this protocol is that it allows the inclusion of user-derived restraints in addition 
to the restraints automatically generated from the sequence alignment. This feature will 
be exploited in our modeling as described in the Methods section below. 
ABC Transporter Crystal Structure Templates 
The first step in the homology modeling procedure described above is to obtain a suitable  
3D crystal structure of a protein closely related to CFTR. Of particular interest are 
structures from the ABC transporter superfamily of which, as mentioned earlier, CFTR is 
a member.  
Our current understanding of structure-function relationships in ABC transporters is 
based on a small number of X-ray structures of varying quality. The structures of the 
bacterial ABC exporters Sav1866 (Figure 2.1A) (determined at a resolution of 3.0 Å) [5] 
and MsbA (3.7 Å) [6] were solved with ATP or non-hydrolyzable ATP analogs bound at 
the nucleotide binding sites. The NBDs in these structures form dimers, whereas the 
transmembrane domains are splayed apart, forming a large cavity accessible from the 
extracellular side. On the other hand, the structures of P-glycoprotein from mouse 
(Figure 2.1B) (determined at 3.8 Å resolution) [7] and E. coli [8] and of two low-
resolution structures (>5 Å) of bacterial MsbA [6] have been determined in the absence 
of nucleotide. The NBDs are disassociated in these structures and far apart spatially, 
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whereas their membrane-spanning domains display an inward-facing cavity accessible 
from the cytoplasm.  
 
 
Figure 2.1: Ribbon representations of the crystal structures of A) Sav1866 [9], B) mouse 
P-gp [7], C) TM287/288 [10] 
 
The crystal structure of TM287/288 (Figure 2.1C), an ABC exporter from T. maritima, 
was recently published at a resolution of 2.9 Å. This structure is of particular interest to 
CFTR researchers due to the presence of a degenerate ATP catalytic site on NBD1 that 
deviates from the ABC consensus sequence in the same positions as CFTR. The 
persistence of nucleotide at that site during crystallization led to the formation of a partial 
dimer structure that is likely to be analogous to the partial dimer C1 state that CFTR 
primarily occupies as its closed channel conformation. 
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Existing Homology Models of CFTR 
 
 
Figure 2.2: Stages in gating cycle of CFTR 
 
Recall, from the proposed gating cycle (shown in Figure 2.2) that CFTR is thought to 
adopt one of several structural states, each of which corresponds to different stages of its 
transition pathway from the functional closed channel to the open channel. Although the 
changes in channel conduction are likely due to structural changes in the channel pore 
and the extra- and intracellular gates (located in the membrane-spanning domains 
(MSDs)), the transition is thought to be precipitated by changes in the structure and 
dimerization interactions of the intracellular nucleotide-binding domains (NBDs). Thus, 
while ATP binding and hydrolysis serve to power the alternating-access pump cycle of 
other ABC transporters, it appears that, CFTR, despite altering its primary role to that of 
a passive ion channel, has retained its ATP binding and catalytic domains to drive the 
gating of its conducting pore. To wit, the binding of ATP at both nucleotide binding sites 
and the resulting tight dimerization of the nucleotide binding domains is thought to be 
essential to channel opening in CFTR [11]. In the search for suitable templates for 
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homology modeling, therefore, it appears likely that an ABC transporter crystallized with 
bound ATP and tightly dimerized nucleotide binding domains would serve as a good 
basis for modeling the open channel O state of CFTR. 
Following this line of reasoning, the elucidation of the complete structure of the bacterial 
multidrug transporter Sav1866 in an outward-facing pose [9] led to tremendous 
excitement in the field and its subsequent use as a template for several homology models 
of the CFTR open channel state [12-17]. The Sav1866 structure has several features that 
makes it a good candidate for use in modeling CFTR. First, it is a multidrug exporter (i.e. 
it was responsible for pumping substrates from the intracellular environment out to the 
extraceullar side) and the sub-family of ABC transporters with closest homology to 
CFTR — the ABC-C subfamily — are all also multidrug exporters. Secondly, it was 
crystallized at sufficiently high resolution to allow determination of important surface-
lining residues and specific inter-residue contacts that may be important in maintaining 
structure (and may thus allow inference of similar information in the modeled CFTR 
structure). Finally, the assembled molecule had a topological layout — two nucleotide 
binding domains and two membrane-spanning domains each with six transmembrane α-
helices and long intracellular loops — similar to CFTR (sans, of course, the unique-to-
CFTR R-domain).  
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Figure 2.3: Existing homology models of CFTR by A) Serohojis et al. [18], B) Mornon 
et al. [13], C) Alexander et al. [19], and D) Dalton et al. [15] 
 
However, researchers quickly realized that, while there was a fair degree of conservation 
between the amino acid sequences of CFTR and Sav1866 in their respective nucleotide 
binding domains, the sequence homology in the MSDs was very low (<20%), making the 
transmembrane segments of CFTR the most difficult to align to the Sav1866 template. 
This is unfortunate, since this region constitutes the conduction pore and is therefore 
critical to CFTR’s function as an ion channel. The implications of this challenge were 
reflected in the quality of the models generated. While the gross structures of all the 
models were similar (Figure 2.3) a closer analysis reveals significant discrepancies in the 
register and secondary structure assignment of these models, with no clear indications of 
any model being clearly better than the others. Prior experimental evidence (particularly 
from electrophysiology experiments) suggested several experimental features that must 
exist in any valid model of the CFTR open channel structure. To our disappointment, 
when we inspected all the models for which coordinates were made available to us for 
conformance to these features, we found that none of them met all the criteria for a truly 
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valid model (Table 2.1). This signaled to us the need for a new model of the open CFTR 
channel state, based on the same Sav1866 template, but designed with cognizance of the 
need to maintain important features known from decades of experimental studies on 
CFTR. 
 
Table 2.1: Expected structural features of CFTR 
 
It also has been suggested that the inward-facing apo state of the typical ABC transporter 
may correspond to the C0 closed channel in CFTR. Such a choice may be justified for 
two reasons. First, the fact that ATP binding is found to be necessary for channel opening 
implies that ATP-free structures of homologous proteins may correspond to the closed 
CFTR channel. Secondly, all the nucleotide-free crystal structures published so far 
display a membrane-spanning domain with a wide cellular cavity that narrows to a close 
in the transmembrane region of the protein. This narrow (in fact, occluded) region may 
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represent the extracellular gate of the CFTR pore, which prevents conduction in the 
closed channel state.  
Mornon et al. [14] proposed such a structure based on homology modeling using as 
template a corrected X-ray crystal structure of the bacterial ABC lipid flippase MsbA [6]. 
However, this template suffered from poor resolution (5.5 Å), compounding the problem 
of alignment described above, and making it more difficult to ascertain the accuracy of 
their homology model. With the publication of new high-resolution (3 Å) ATP-free apo 
crystal structures of the P-glycoprotein [7,8] — which, like CFTR’s nearest relatives, is 
also a multidrug exporter, and also has twelve transmembrane helices — we saw an 
opportunity to improve the state-of-the-art once more with the creation of a new 
homology model of the closed channel state of CFTR based on P-glycoprotein. 
Methods 
Homology Modeling of the Open State 
Sequence Alignment 
A homology model of the open state of CFTR was created using the crystal structure of 
Sav1866 [5] as a template. As a general rule of thumb, homology modeling based on 
amino acid sequence comparison alone is thought to be reliable only if the sequence 
similarity between the target and the template exceeds 30%. Due to low sequence 
homology between CFTR and Sav1866 in the membrane-spanning domains (~16%), we 
had to seek out alternative strategies to increase our confidence in our alignment.  
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It has been demonstrated that the addition of additional profiles to the alignment can aid 
in generating better end results. Analogous to the dictum “(3D) structure is more strongly 
conserved than sequence” — the very basis of comparative modeling — it has been 
observed that other features such as secondary structure elements, patches of 
hydrophobicity, and regions of transmembrane embedment are also strongly conserved 
even in the face of changing sequence over the course of evolution. For example, if a 
protein contains a span of sequence that forms a transmembrane alpha helix, one may 
reasonable expect that the overall helicity of this region — a property of its amino acid 
composition — is maintained in a comparable structural region in its close homologs, 
even if the exact amino acid sequence is not. Similarly, one may also expect the 
amphipathic nature of this helix (due to the fact that it is alternately pore-facing and 
membrane-facing) to also persist in homologous proteins, perhaps to a greater degree 
than the particulars of its amino acid sequence. There exist algorithms that can predict, 
based on sequence, the propensity of a particular sequence region to form particular 
secondary structure elements, its hydrophobicity, and its likelihood of being embedded in 
a membrane. It has been demonstrated [20] that superimposing and aligning the results 
from these prediction algorithms for both the template and target sequences can greatly 
improve accuracy of conventional amino-acid-substitution-based alignments.  
In creating an open state model, a sequence alignment between human CFTR and S. 
aureus Sav1866, we generated profiles based on sequence homology (using the 
BLOSUM62 substitution matrix), a sliding-window average of predicted hydrophobicity 
(using the KD hydrophobicity scale [21]), PSIPRED predictions of secondary structure 
[22], and OCTOPUS transmembrane topology predictions [23]. These were used as 
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weighted inputs to the program AlignMe [20]. In addition, the correct alignment of 
buried and exposed residues in transmembrane helix 6 (TM6) and 12 (TM12) was 
enforced by adding a custom measure of similarity to the AlignMe input. First, a profile 
of percentage solvent accessible surface areas was generated for each residue in the 
Sav1866 template in TM6 and TM12 using VMD [24]. A counterpart profile on the 
CFTR sequence was then generated by conducting an extensive literature review on 
CFTR structure-function studies that reveal information on whether particular residues in 
these important pore-lining helices are exposed (i.e. pore-facing) or buried (i.e. in the 
faces of the helix turned away from the pore), including cysteine scanning and open pore 
blocker experiments. Residues in the CFTR profile were assigned a score of 100 if 
predicted to be exposed, 0 if buried. The program then used this information to align 
residues in the CFTR sequence thought (from experiment) to be pore-accessible to sites 
on the Sav1866 template with high solvent-accessible surface areas (from the crystal 
structure). The region of the CFTR sequence containing the R-domain (residues 650 
through 856) was omitted from all of the modeling in this study, since no analogous 
structure exists in the ABC templates, and it is in fact thought to be largely unstructured 
[25].  
Restraint-based Homology Modeling 
The Sav1866 template structure was crystallized with ADP at both NBD binding sites, 
but these were removed in our homology models. Homology modeling was carried out in 
Modeller v. 9.10 which efficiently implements the method of Sali & Blundell described 
earlier [4]. An advantage of this method of homology modeling is the ability to add user-
defined spatial restraints to the final structure. Our group and others have demonstrated 
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the existence of salt-bride interactions between the residues R347-D924 [26] and R352-
D993 [27]. In addition, several residues in the nucleotide binding domains and the intra-
cellular loops are thought to be cross-linkable, suggesting they exist in the open state in 
close spatial proximity. This allowed us to supply a set of distance restraints (Table 2.2) 
in the form of soft semi-harmonic potentials to further refine the model. In the modeler 
protocol, these restraints were added to those automatically generated based on the 
provided template structure (Sav1866, PDB: 2HYD) and sequence alignment (from the 
AlignMe results above), to create initial models that were then subjected to 5000 steps of 
conjugate gradient energy minization and a standard simulated annealing protocol using 
molecular dynamics. Ten models were thus generated, and then evaluated based on 
observed maintenance of the known salt bridges and solvent accessibility of predicted 
pore-lining residues in TM6 and TM12. The best of these — henceforth referred to as the 
O-CFTR model — was chosen for further study.  
The stereochemical quality of the final model was validated using PROCHECK [28]. The 
radius profile of the ion conduction pore along the axis normal to the lipid bilayer was 







Table 2.2: Distance restraints used in homology modeling of O-CFTR 
Residues Distance Reference 
R352-D993 ≤ 5 Å (salt bridge) {Cui:2008hh} 
R347-D924 ≤ 5 Å (salt bridge) {Cotten:1999vr} 
M348-T1142 ≤ 13 Å {Chen:2004jy} 
T351-T1142 9 Å ≤ d ≤ 13 Å {Chen:2004jy} 
S605-A1374 ≤ 8 Å {Mense:2006et} 
S549-S1248 ≤ 8 Å {Mense:2006et} 
S434-D1336 8 Å ≤ d ≤ 16 Å {Mense:2006et} 
S549-S1374 8 Å ≤ d ≤ 16 Å {Mense:2006et} 
Homology Modeling of the Closed State 
Sequence Alignment 
A similar procedure to that described above was used to generate a sequence alignment 
between CFTR and the closed state template, murine P-glycoprotein (PDB: 3G5U) [7], 
using sequence, hydrophobicity and predicted secondary structure information. An 
interesting observation was made prior to generating the sequence alignment: an initial 
comparison of the lengths of the extracellular loops revealed similarities between lengths 
of the extracellular loops (ECLs) of the first membrane-spanning domain (MSD1) of 
CFTR and the second (MSD2) of P-gp and vice versa (Figure 2.4). Furthermore, we 
noted that the site of N-glycosylation in the ECLs occurs in ECL4 (the first ECL of 




Figure 2.4: Membrane topologies of A) CFTR and B) P-gp. 
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align MSD1 of CFTR with MSD2 of P-gp, and vice versa. Given the low sequence 
homology between P-gp and CFTR in the MSDs, it is not possible to determine whether 
this domain switching has biological significance. However, the assertion that full-
transporters such as CFTR and P-gp may have been independently assembled from 
ancestral half-transporter genes [30] does not preclude this possibility.  
Homology Modeling 
Unlike in the modeling of the open state, we did not have a large body of structural 
information that could be incorporated in our modeling of the closed state. This may, in 
part, be due to the fact that it is difficult to design experiments in which one can 
definitely conclude that the protein was present and in the closed channel conformation. 
We can reasonably expect, however, that gross reorganization of the transmembrane 
topology would not occur in the transition from the closed state to the open state. That is 
to say, residues embedded in the transmembrane region in the creation of the O-CFTR 
already built model were expected to persist in the membrane in the closed state model. 
We thus first generated predictions of the position of the transmembrane region in the O-
CFTR model using the Orientation of Proteins in Membranes (OPM) database [31]. This 
information was added to as a profile to the CFTR sequence, and the corresponding 
profile in the P-gp sequence was generated by inspection of the template P-gp structure. 
In this way, residues predicted to be in the transmembrane region in the O-CFTR model 
were aligned to corresponding transmembrane residues in the P-gp template, ensuring 
topological consistency between our two generated models. No additional restraints were 
used during modeling in Modeller 9.10.  
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PROCHECK was used to check stereochemical quality of the generated C0-CFTR model 
which revealed 93% of the residues to be in the most-favored regions, 7% in allowed 
regions, and none in disallowed regions. 
Results 
New Homology Model of the Open CFTR Channel 
We created a homology model of the open-channel state of CFTR based on a Sav1866 
template using the comparative modeling method of Sali & Blundell [4]. The full protein 
was modeled, with the exception of the unique-to-CFTR R-domain, for which a suitable 
homologous structure could not be found. Due to low sequence homology (particularly in 
the MSDs), primary structure alone could not be used to generate a reliable alignment. 
Instead, a combination of secondary structure predictions, hydropathy analysis, and pore 
accessibility indicators were incorporated into the alignment (Figure 2.5). Soft semi-
harmonic restraints were manually added between particular residues in order to ensure 
that established salt bridges and distance constraints derived from disulfide crosslinking 
experiments in CFTR double cysteine mutants were satisfied. Ten such models were 
generated and energy-minimized using a simulated annealing protocol, then ranked based 
on maintenance of the established R347-D924 [26] and R352-D993 [27] salt bridges, and 
accessibility of residues in TM6 and TM12 predicted to be pore-lining. The model that 
best fit these criteria (designated O-CFTR) was chosen for further study (Figure 2.6). 
PROCHECK was used to check the validity of our model, and showed 95% of residues to 
be in the most favorable regions with none in disallowed regions (Figure 2.7). 
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Figure 2.5: Sequence alignment used to generate O-CFTR model 
 
Figure 2.6: Ribbon representation of O-CFTR model 
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Figure 2.7: Ramachandran plot of O-CFTR model 
 
By design, the O-CFTR model contains several structural features expected to be found 
in the real CFTR structure. The established R352-D993 and R347-D924 salt bridge 
residue pairs are observed in our model to have side chains oriented toward each other 
with distances <5 Å between their interacting guanidinium and carboxyl groups (Figure 
2.8). This is in contrast to existing homology models, none of which correctly depicts 
these salt-bridges. Indeed, when we add our O-CFTR model to the list of expected 
features that motivated our modeling project, we are vindicated by the finding that our 
model does in fact meet all the criteria we had initially set for it. Not that several of these 
criteria were not explicitly controlled for, but were rather bona fide predictions of our 
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model. This gives us confidence that our model can, in fact be used to make useful 
predictions about CFTR structure and function.  
 
 
Figure 2.8: Salt bridges in O-CFTR model 
 
We also reviewed the surface accessibility status of predicted pore-lining residues in the 
critical TM6 [27,32-42] and TM12 [32,43-46] helices. In order to determine accessibility 
status, we measured the percentage of the total surface area accessible to solvent for each 
residue of interest in each available model. A commonly employed cutoff of 20% was 
used as a classifier threshold [47]. Analysis of solvent-accessible surface area in these 
helices revealed that our O-CFTR model has more of these residues exposed to the 
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aqueous conduction pore than several previous open-state models, including those of 
Serohijos et al.[18], Mornon et al. [14], Dalton et al. [15], and the 5 ns snapshot of the 30 
ns molecular dynamics (MD) simulation obtained from Norimatsu et al. [16] (Table 2.3). 
Of 18 residues expected to be pore-accessible based on cysteine scanning and open pore 
blocker experiments, 12 were predicted to be accessible (>20% surface area accessible to 
solvent) in our model. 
Table 2.3: Pore accessibility of residues in TM6 and TM12 
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Interestingly, decreased sensitivity to open pore blockers by mutations at V350 [42] have 
suggested its important role in CFTR channel structure, but none of the Sav1866-based 
models, including our current model, show it to be accessible from the pore. V1147 on 
TM12, also thought to be pore-accessible [42,45] is similarly buried in all the models. 
This suggests that the effects of mutations at V350 and V1147 are indirect, or that a 
departure of CFTR structure from the Sav1866 template exists at the cytosolic end of the 
transmembrane region. Indeed, a drawback of our model is that there is no clear entrance 
to the transmembrane pore from the cytoplasmic end, a consequence of the alternating-
access exporter function of the Sav1866 template shared by most existing homology 
models of the open CFTR channel. 
A closer inspection of the pore structure in the transmembrane region of our O-CFTR 
model was conducted using the program HOLE [29] (Figure 2.9). This program traverses 
the model structure in the direction parallel to the pore axis, mapping the largest discs 
that can be circumscribed within the pore at every height and returning the pore radius 
profile as a function of distance along the axis. In addition, it also can also be used to 
generate graphical representations of the pore. This analysis reveals the pore radius in our 
O-CFTR model to be continuously larger than 3.6 Å (the diameter of a dehydrated 
chloride ion [48]), indicating that the channel shown in our model is indeed open to 
conduction. We note also the existence of a narrow region, centered upon S341 in TM6 
and T1134 in TM12, which separates the transmembrane pore into an inner and outer 
vestibule. This pore architecture is consistent with recent predicted models [15,16] as 
well as with experimental evidence suggesting the existence of a wide inner vestibule 
capable of binding pore-occluding blockers [49], and the narrowing of the pore in the 
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region of S341 [16]. Interestingly S341 is thought to play a vital role in anion selectivity 
in CFTR, and its structural position in the narrow region of the pore may be vital to its 
discriminatory role [33]. 
 
Figure 2.9: Close-up of the transmembrane pore in O-CFTR 
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New Homology Model of the Closed CFTR Channel 
In addition to a Sav1866-based open state model, we also created a model of the 
proposed nucleotide-free closed state of CFTR using the inward-facing X-ray crystal 
structure of murine P-glycoprotein (P-gp) [7] as a template.  
Prior to generating a sequence alignment between CFTR and P-gp, we noted a 
discrepancy in the sizes of the extracellular loops (ECLs) in the P-gp structure and our 
proposed O-CFTR model. In particular, ECL1 between TM1 and TM2 in P-gp (~41 
residues long) was much larger than ECL1 in O-CFTR (~12 residues), but similar in 
length to ECL4 between TM7 and TM8 in O-CFTR (~33 residues) (Figure S2). 
Therefore, in order to facilitate modeling, we chose to use P-gp’s MSD1 as a template for 
CFTR’s MSD2 and vice versa. A similar procedure to that used in generating the open 
state model was then followed, creating a sequence alignment between CFTR and mouse 
P-gp and manually adjusting it to ensure a topological match between the O-CFTR model 
already generated and the closed state model (Figure 2.10). The final closed state 
homology model (Figure 2.11) was created in MODELLER, and validated for 
stereochemical quality using PROCHECK [28]. 
As may be expected from the structure of the P-gp template, the NBDs in C0-CFTR are 
completely dissociated, and the MSDs tilt toward each other to form a constriction near 
the extracellular end of the transmembrane region. This gate, comprised of the 
extracellular-end residues in TM6, TM12, TM1 and TM7 along with ECL1, ECL3, 
ECL4, and ECL6, and perhaps with contributions from N-linked glycans (not modeled) 
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in ECL4, provides an effective barrier to permeation, consistent with the observation that 
the CFTR channel is closed in the absence of NBD dimerization. 
 
Figure 2.10: Sequence alignment used to generate C0-CFTR model 
 
Figure 2.11: Ribbon representation of C0-CFTR model 
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State-Dependent Accessibility of R334C 
The arginine at position 334 on TM6 lies at the outer mouth of the pore, and has been 
suggested to play a role in attracting anions [50,51]. It has been observed, however, that 
modification of cysteine mutants at this site (R334C) occurs only in the closed state, with 
the site apparently being inaccessible when the channel is open [52-54]. Norimatsu et al. 
[54] have suggested that this state-dependent accessibility may be due to movement of 
residues neighboring R334, and a comparison of this region in our two models provides 
support for this hypothesis. In an open state O-CFTR model in which the arginine at 
position 334 was mutated to a cysteine in silico, R334C is buried by many of its 
neighboring residues in ECL3 and is found to have a fractional solvent-accessible surface 
area (SASA) of only 3.8%. By comparison, the C0-CFTR model presents R334C in a 
relatively exposed conformation, with 32.9% of its surface area accessible to solvent 
(Figure 2.12). This increased accessibility may translate to the higher observed rates of 
reaction of R334C with extracellular sulfhydryl-modifying reagents in the closed state. A 
similar SASA analysis of the C0-CFTR and O-CFTR models with the native arginine 
residue reveals that this position may exhibit similar state-dependent accessibility in 
wildtype CFTR (Figure 2.13). 
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Figure 2.12: State-dependent accessibility of R334C 
 
 





New Homology Models 
Understanding structure-function relationships in CFTR will aid in the development of 
therapeutic treatments for the underlying cause of CF. Data from experimental studies, in 
addition, provide insight about functional states (also reflecting ensembles of conformers) 
and interactions that are more likely than others. Our aim in this study was to create a 
single consensus model that best incorporates much of the available experimental 
information about the CFTR open channel structure. Previous models proposed by 
Serohijos et al. [18], Alexander et al. [19] and Norimatsu et al. [16] did not include the 
established salt bridge between residues R347 and D924 [26], and the R352-D993 [27] 
salt bridge interaction did not exist in the open state model of Mornon et al. [14]. Our 
Sav1866-based O-CFTR model correctly accommodates all of this structural information, 
and, like the models from Dalton [15] and Norimatsu [16] and colleagues, contains a 
transmembrane pore region depicting inner and outer vestibules separated by a narrow 
region near the selectivity-conferring residues S341 and T338 [33]. Our C0-CFTR closed 
channel model uses a mouse P-gp template reported at much higher resolution than the 
MsbA structure previously used by Mornon et al. [14]; our model also included a swap of 
the N- and C-terminal to improve the alignment (see Methods) that we believe provides a 
superior alignment than the naïve implementation. 
Although CFTR is thought to cycle between a closed state with partially-dimerized NBDs 
(C1) and a tight-dimer open state (O) during its action as a chloride channel, it is also 
known to transport large substrates such as the glutathione antioxidant tripeptide (GSH) 
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[55]. Given the disparity in size between the chloride ion and GSH, transport of GSH 
may require the much larger inner vestibule provided by the fully NBD-dissociated state 
represented in our C0-CFTR model. 
While some experimental data, such as the salt bridge interactions and accessibility of 
pore-lining residues, were built into our models as constraints, we also observe that the 
models accurately predict results that were not explicitly controlled for during model 
generation. For example, cysteine mutants at residue R334 in the outer mouth of the pore 
[52-54] have been demonstrated to be more reactive to MTS reagents in the closed 
channel state than in the open channel. This residue is more exposed in our C0-CFTR 
model than in our O-CFTR model. These findings give us confidence in the predictive 
power of these models and in their ability to explain and interpret functional data in terms 
of specific structural changes in the CFTR molecule. It is our hope that these improved 
models of CFTR will serve as a useful visualization tool for experimenters in designing 
and interpreting results from structure-function studies, and as an accurate reference state 
from which to begin simulation studies of CFTR. 
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TARGETED MOLECULAR DYNAMICS SIMULATIONS OF 
CHANNEL OPENING IN CFTR 
Abstract 
We have employed a targeted molecular dynamics simulation using the C0-CFTR model 
as an initial structure and O-CFTR model as a target to investigate the conformational 
changes CFTR undergoes during channel opening. In our simulations, the most 
significant change during the initial stages of the transition involved the translation of the 
NBDs toward each other, and the concomitant contraction of the cytoplasmic vestibule. 
Such an NBD-initiated transition is consistent with the long-standing hypothesis that 
ATP binding at the NBDs initiates channel opening in CFTR. Snapshots of our 
simulation trajectory yield structures that bear close resemblance to the proposed 
intermediate states of CFTR during its gating cycle. Through our simulations, we have 
discovered a novel salt bridge between R334 and E217 predicted to break during channel 
opening which was confirmed experimentally using functional crosslinking. Notably, 
many of the amino acids that participate in other interactions predicted by our simulations 
are also involved in CF disease-associated mutations. These predictions should offer 
insight into the structural defects that lead to CFTR dysfunction in these mutants, and, 




In the previous chapter, we built new homology models of the closed and open channel 
states of CFTR, which we believe constitute the most accurate representations of CFTR 
structure in its various functional states to date. Our model structures are highly 
consistent with the available experimental structure-function data on CFTR, and also 
demonstrate excellent predictive and explanatory potential by uncovering structural 
features that are highly plausible (in light of available experimental data) even though 
they were not explicitly constrained during modeling. Despite these advantages, however, 
we are bound to admit that these models represent mere “snapshots” of a large ensemble 
of possible structures that the CFTR protein likely adopts in its native environment. No 
biological system exists in vacuo; they are all subject to myriad interactions with their 
surrounding environment. A single CFTR molecule resides in a complex milieu of mixed 
aqueous (at its nucleotide-binding and intracellular and extracellular loop domains) and 
non-polar (at its transmembrane domains) environments with which it constantly interacts 
through kinetic, electrostatic, van der Waals, and hydrophobic forces. Thus, while our 
static models may represent accurate estimates of aggregate “consensus” states, they are, 
nevertheless, convenient fictions that do not capture the dynamics and ensemble behavior 
of the real molecule. 
In addition, we note that our model for the closed state was modeled on a template (the 
crystal structure of murine P-glycoprotein [1]) that did not contain bound nucleotide at 
either of CFTR’s two ATP binding sites (ABSs). The ABSs are composed of motifs from 
both the N-terminal and the C-terminal nucleotide-binding domains (NBD1 and NBD2, 
respectively), and formation of the ABSs is dependent upon NBD dimerization, 
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precipitated by ATP binding. ATP hydrolysis and release leads to de-dimerization, and 
the NBDs in this structure are consequently completely separated (and, therefore, also in 
our model of C0-CFTR based on this structure). However, unlike most other ABC 
transporters including P-gp, one of CFTR’s ATP binding sites (ABS1) has impaired 
(perhaps abolished) catalytic activity. While this site is capable of binding to an ATP 
molecule, it cannot subsequently hydrolyze and release the nucleotide. Indeed, gating in 
CFTR is thought be controlled primarily by ATP binding and hydrolysis at the other 
binding site (ABS2), while ATP is retained at the degenerate ABS1 over several gating 
cycles [2]. The NBDs cannot, therefore, de-dimerize at this location, and CFTR is instead 
to occupy a “partial dimer” structure with ATP retained at ABS1 during the dominant 
closed channel phase of its gating cycle (C1). The fully de-dimerized state represented by 
our P-gp based C0-CFTR model is thought to be rarely visited under physiological 
conditions with ATP [3]. 
In order to investigate the dynamic nature of the protein molecule, as well as to visit 
intermediate states between the extremes represented by the models we developed in the 
previous chapter, we turn to the methods of molecular dynamics. 
Molecular Dynamics 
Molecular interactions and the resulting forces that drive their dynamics are accurately 
described by quantum mechanics and the solutions to Schrödinger’s equation. If we know 
the positions and quantum states of every atom in a system, we can describe the forces 
acting on each atom and the evolution of the system over time. Due to the large number 
of parameters and the incredibly complex computations involved in such a calculation, 
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however, solving this problem using currently available computational tools is infeasible 
for large biological macromolecules. 
One common approach to solving this problem for N-body systems  is to use the 
molecular mechanics (MM) approximation. Several simplifying assumptions must be 
made in applying MM computation to a system. First, every atom is treated as a single 
spherical particle, with a volume typically corresponding to the Van der Waals radius for 
that atom. Secondly, atoms are assigned “partial charges” depending on their type and 
context, and electrostatic interactions between distant atoms are treated as Coulombic 
forces. Finally, the functional forms of bonded interactions are truncated to second-
degree polynomials, allowing them to be treated as Hookean springs with pre-defined 
equilibrium bond lengths and spring constants. “Bonded interactions” typically include 
distance restraints between two bonded atoms, restraints on the angle subtended by three 
bonded atoms, and restraints on the dihedral angle between four atoms bonded in a chain. 
Parameters for each of these terms (e.g. partial charge values, spring lengths and force 
constants) may be empirically derived or fitted from first-principle quantum mechanical 
calculations on smaller molecular systems. There may exist additional interaction terms, 
added (often empirically) to improve the accuracy of the resulting “molecular mechanics 
force field”, and the exact functional forms of all the interactions vary by 
implementation. For instance, one common MM potential that is popular for 
biomolecular simulations is the CHARMM22 force field [4], defined as: 
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Given the position of every atom in a system, information about the atomic parameters 
(mass, charge, radius), and a graph of the bond connectivity between atoms, one can use 
the equation above (or its equivalent for some other force field) to calculate the 
conformation-dependent energy (termed the MM energy) for any given “snapshot” of a 
system. 
Molecular dynamics (MD) takes this idea a step further, by postulating that the dynamic 
evolution of a system can be calculated by integration of Newton’s laws of motion for a 
system governed by a molecular mechanics potential of the form given above. To wit, the 
above equation can be used to calculate the forces on each atom and, since we also know 
the assigned mass of each atom, we can calculate the acceleration of each atom using 
Newton’s Second Law of Motion. Thus, given initial positions, velocities and masses, 
once can compute (deterministically) the motions of a molecule under a given MM 
potential. 
The dynamic nature of the system necessitates numerical integration as a function of 
time. Since the potential energy terms in Equation 3.1 depend on the conformation of the 
system, and the conformation of the system, in turn, evolves in response to these energy 
terms, one must alternate between computing the forces on the atoms and their evolving 
positions and velocities. The characteristic “timestep” for this integration is governed by 
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the highest frequency motions within it. In atomistic simulations of molecules, the short 
period of the C—H bond vibrational typically limits MD timesteps to 1 or 2 
femtoseconds. 
Note that the MM potential in equation 3.1 is a linear superposition of several different 
force types, and that it can be extended to include user-defined forces on a system (e.g. 
the force of an AFM tip pushing on a molecule). 
MD Simulations of CFTR 
MD simulations have previously been used to study the dynamics of existing homology 
models of CFTR. The first such attempt was made by Alexander et al. [5], and they 
illustrated the utility of MD simulations of CFTR by demonstrating the formation of the 
R352-D993 salt bridge [6] which did not exist in their initial model over the course of a 5 
ns MD simulation. These simulations were subsequently extended by Norimatsu et al [7]. 
The longest simulations of CFTR to date have been carried out by Furukawa-Hagiya et 
al. [8]. Unlike in previous attempts that ran MD on open channel CFTR models, they 
began their simulations with CFTR in the closed channel state. Through MD simulations, 
they tested the hypothesis that ATP binding at the nucleotide-binding domains causes 
conformational changes that propagate to the membrane-spanning domains (MSDs), 
ultimately resulting in channel opening. However, even when they extended their 
simulations out to 100 ns, they failed to detect significant changes in the conformation of 
the MSDs. This could have been due to poor modeling of the interactions between MSDs 
and NBDs responsible for transducing the conformational signal, a failure of the MM 
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potential to capture the motions of the molecule with sufficient accuracy, or simply 
because the simulations were not extended long enough. It must be noted, however, that a 
100 ns simulation approaches our current limits with regards to feasible MD simulations 
on systems of this size. Furthermore, the accuracy of the MM potentials when used over 
longer timescales can also be called to question (particularly due to the increased 
accumulation of integration errors). 
When deciding on MD simulation techniques, therefore, we realized the “free” MD 
simulations where no forces other than the internal molecular forces were allowed to act 
on the system would not be particularly informative over the timescales accessible to us. 
Fortunately, alternative techniques that employ user-defined forces to study particular 
transition pathways exist, and we have employed one of these approaches — targeted 
molecular dynamics (TMD) — in the studies that follow. In particular, we employed 
TMD to study the evolution of our C0-CFTR closed channel model towards the structure 
of the O-CFTR open channel structure in a simulation designed to mimic one possible 






Targeted Molecular Dynamics 
System Set-up 
In order to carry out a realistic simulation of a channel opening event, the closed state-
protein model, C0-CFTR, was first embedded in an simulation box mimetic of its cellular 
environment.  
First, the C0-CFTR model was put in the correct orientation by structurally aligning it 
with the P-gp template downloaded the Orientation of Proteins in Membranes [9] 
database. The membrane protein structures stored in this database are positioned such 
that they intersect an imaginary membrane bilayer centered on the x-y plane (with the 
positive z-axis pointing in the extracellular direction), using predictions based on the 
nature of the residues at the surface of the protein (e.g. there will be a high propensity for 
hydrophobic surface residues to be positioned near the hydrophobic core of the 
membrane bilayer). Next, a 120 Å×120 Å membrane patch consisting of 343 1-palmitoyl-
2-oleoylphosphatidylcholine (POPC) residues was generated in VMD [10]. This patch 
was generated by duplicating square patches of POPC residues arranged in a bi-layer 
with density and bilayer thickness set to match physiological values. Disorder was 
introduced into the patches by randomizing the orientations of the lipid molecules. The 
correctly-oriented C0-CFTR molecule was placed within the generated lipid bilayer, and 
lipid molecules within 0.6 Å of any protein atom were deleted, in addition to any lipid 
molecules within the protein cavity. The system was then solvated by the randomized 
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addition of water molecules. Due to the large number of water molecules in a typical 
biomolecular simulation, significant computational savings can be had by implementing a 
simplified model for each molecule. In these simulations, a 3-site water model for which 
the CHARMM27 potential was optimized called TIP3P [11] was used, and a total of 
51,636 water molecules were added to the system. 146 K+ atoms and 155 Cl− atoms were 
also added to neutralize the net charge of the system and bring the ionic strength of the 
solution up to 150 mM. The full simulation box measured 120 Å × 120 Å × 165 Å and 
comprised 218,356 atoms (Figure 3.1).  
 
 
Figure 3.1: Snapshot of a unit simulation box 
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MD Simulations 
NAMD 2.8 [12] was used for all simulations on this system, using the CHARMM27 
force field [4] in a Langevin temperature and pressure controlled (NPT @ 300K) 
ensemble. The boundaries of the simulation box were set to be periodic (i.e. images of the 
unit cell extend infinitely in every dimension). Long-range electrostatics calculations in 
such a periodic system are easily computed using particle-mesh Ewald summation 
method. The SHAKE algorithm [13] was used to fix hydrogen bonds allowing the use of 
a 2 fs timestep. 
First, 5000 steps of conjugate gradient energy minimization to remove steric clashes 
within the system as set up (i.e. atoms that were positioned within Van der Waals radii of 
each other). The lipid membrane tails in the original set-up are artificially straight (in 
order to facilitate protein insertion), and were first allowed to “melt” together to remove 
gaps between the generated patch and the embedded. In order to do this, all the atoms of 
the system except for the membrane hydrophobic tails were frozen, and then a short (1 
ns) MD simulation was run in order for the membrane tails to equilibrate. This was 
followed by a 10 ns MD equilibration of the entire system with only the protein held 
restrained, carried out primarily in order to allow the surrounding solvent to equilibrate 
and arrange itself around the protein molecule. Finally, the entire system was allowed to 
equilibrate for a further 10 ns.  
Targeted molecular dynamics (TMD) simulations were then carried out in order to 
transform the C0-CFTR state to the open channel O-CFTR state. In the method of 
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targeted molecular dynamics used here, a TMD force is added to MM potential (Equation 
3.1) of the form: 
 VTMD = kTMD RMSD(t)− RMSD*(t)( )
2  (3.2) 
In order to apply this force, we first defined a set of target coordinates. This was provided 
by the coordinates of our O-CFTR model, which were aligned to the OPM structure of 
Sav1866 as described earlier for our C0-CFTR model. RMSD(t) in the above equation is 
then calculated to be the instantaneous best fit root-mean-square-displacement of the 
backbone C-α atoms at time t after the start of simulations from the target coordinates 
(the O-CFTR model). The RMS*(t) term evolved linearly from the initial RMSD 
(RMSD(0), i.e. the RMSD between the C0-CFTR model and the O-CFTR model) to zero 
over the course of 10 ns. This added term, therefore, has the effect of reducing the RMSD 
between the protein and the target as the simulation progresses. The TMD force constant, 
kTMD, was set to 5 kcal/(mol Å2).  
Snapshots of the simulation trajectory taken at 0 ns, 2.5 ns, 5 ns, 7.5 ns, and 10 ns were 
saved and their pores were analyzed along the axis normal to the lipid bilayer using the 
program HOLE [14]. Distances between interacting pairs of residues were measured 
using VMD [10]. 
Electrophysiology Experiments 
Experimental validation of the models was carried out in the lab of Dr. McCarty at 
Emory, primarily by Dr. Guiying Cui. Experimental approaches were identical to those 
described in detail previously [6]. To wit, stage V-VI oocytes were isolated from 
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Xenopus laevis, under a protocol approved by the IACUC at Emory University, and 
injected with cRNA encoding wildtype human CFTR or mutants bearing cysteines 
engineered at position 334 and/or 217 on the wildtype background. Macroscopic currents 
were measured using an Axon Axoclamp 900A amplifier (Molecular Devices, 
Sunnyvale, CA) at a holding potential of –60 mV, and were activated upon stimulation of 
the co-expressed human beta2-adrenergic receptor by exposure to 10 µM isoproterenol 
added to the bath solution (ND96, containing in mM 96 NaCl, 2 KCl, 1 MgCl2, and 5 
HEPES, pH 7.5). Cells were exposed to 1 mM 1,2-ethanediyl bismethanethiosulfonate 
(MTS-2-MTS; Toronto Research Chemicals, Canada) in the presence or absence of 
isoproterenol. 
Results 
Targeted Molecular Dynamics Simulations 
We employed TMD simulations to generate a possible molecular trajectory of a channel 
opening event. Our initial simulation system consisted of the C0-CFTR homology model 
embedded in a POPC lipid bilayer membrane patch and solvated in a 150 mM KCl 
solution with explicit TIP3P water molecules. A biasing force was applied to the 
backbone C-α atoms to reach the O-CFTR target structure over a 10 ns simulation, 
arriving at a final RMSD between the simulation structure and O-CFTR of ~0.3 Å. 
Snapshots of the progressing simulation were taken at 0 ns, 2.5 ns, 5 ns, 7.5 ns, and 10 ns, 
and are further analyzed below (Figure 3.2). The PDB coordinate files for each of these 
snapshots can be found at: http://harvey.gatech.edu/cftr/PLoSONE_2013/. 
 58 
 
Figure 3.2: A) Snapshots along the TMD simulation, B) Corresponding states of CFTR’s 
gating cycle 
 
Visual inspection of the TMD trajectory reveals a progressing “conformational wave” 
during the opening transition (Figure 4), similar to that seen in nicotinic acetylcholine 
receptors during their transition between closed and open states [15]. This comprises 
three main stages:  
1) pushing together of NBDs and contraction of the inner vestibule (C0 ! C1),  
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2) NBDs forming a tight dimer and bending at the intracellular extensions of the TM 
helices that form the intracellular loops (ICLs) (C1 ! C2), and  
3) propagation of conformational change through TM helix rotation plus translation 
of the two transmembrane “wings” of the molecule — comprised of TM1 + TM2 
+ TM9 + TM10 + TM11 + TM12 and TM7 + TM8 + TM3 + TM4 + TM5 + 
TM6, respectively — away from each other in the direction perpendicular to the 
NBD dimer interface (C2 ! O).  
This sequence of events is further corroborated by analysis of the pore radius profiles for 
each of the snapshots taken during the trajectory. The dominant pore in each snapshot 
was analyzed using the program HOLE [14], and is depicted in Figure 3.2 as a tube 
within the protein cavity, colored blue for regions with radius > 3 Å, green where the 
pore radius is between 3 Å and 1.8 Å, and red where the radius is < 1.8 Å, indicating that 
it is too narrow to allow chloride conduction. As noted, we see a contraction of the 
cellular cavity over the first half of the simulation due to NBD dimerization. During this 
period, the pore is never larger than a chloride ion indicating that all the structures 
generated until this stage correspond to closed CFTR channels. At 7.5 ns NBD 
dimerization is more or less complete, and we finally see unbending of the intra-cellular 
loops that leads to expansion of the transmembrane pore. At this stage we finally see a 
pore large enough to allow chloride conduction, indicating that this structure likely 
corresponds to the open CFTR channel. The conformation transition completes over the 
last quarter of the simulation with further expansion of the pore leading to the full 
conductance state at 10 ns.  
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This NBD-initiated transition pathway is consistent with the notion that ATP binding 
regulates channel gating by driving conformational changes in the transmembrane pore 
[16].  
Note that we have chosen the labels for these snapshots (C0, C1, C2 and O) to coincide 
with the nomenclature used to describe the various functional states of CFTR on purpose, 
since we believe that each of these structures best corresponds to these functional states. 
For instance, we believe that the C1-CFTR structure at 2.5 ns represents the C1 partial 
dimer state that CFTR primarily occupies as a closed channel. Due to the similarity of its 
asymmetric nucleotide binding domains to those proposed in CFTR, a recently published 
crystal structure of the bacterial ABC transporter TM287/288 [17] that has nucleotide 
bound in the degenerate catalytic site may serve as a useful template for the C1 partial 
dimer state of CFTR. A comparison of the NBDs from this structure to those in our 
snapshots confirms that the 2.5 ns snapshot of our TMD trajectory most closely 
resembles the purported partial dimer closed state of TM287/288 (Figure 3.3). 
 
Figure 3.3: Comparison of NBDs from simulation and TM287/288 structure. A) Overlay 
of  TM287/288 (red) and 2.5 ns snapshot (green). B) RMSD distance betwee TM287/288 
and various snapshots. 
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Tracking Conformational Changes 
In order to track the progression of the conformational wave as it travels from the NBDs 
through the ICLs to the transmembrane region, we charted the formation and breaking of 
the residue pair interactions shown in (Figure 3.4A) over the course of the simulation. In 
the NBDs, we tracked the distance between the side chains of residues R555 (NBD1) and 
T1246 (NBD2), which have been suggested to participate in a hydrogen bond interaction 
upon NBD dimerization [16]. In the TM helices, the formation of the R352-D993 [6,18] 
salt bridge was followed. In the ICLs, we discovered a novel salt bridge interaction 
between residues R258 and E282 in our simulations that exists in the closed state but is 
broken in the transition to the open channel as the passing conformational wave causes 
these residues to move apart. 
Tracking these interactions over the course of the 10 ns simulation confirms the overall 
direction in which the transition progresses across the different domains of the protein 
(Figure 3.4B). The distance between R555 and T1246 decreases monotonically over the 
first 4 ns of the simulation as the NBDs are pushed together, and is then locked with the 
formation of a stable hydrogen bond at ~5 ns. The breaking of the closed-state R258-
E282 salt bridge follows at ~6 ns, as the intracellular extensions of TM4 and TM5 slide 
past each other with the contraction of the cytoplasmic vestibule. The conformational 
wave then leads to rotations in TM6 and TM9, bringing residues R352 and D993 closer 







Figure 3.4: Tracking the conformational changes in CFTR channel opening by following 
particular side-chain interactions. A) Close-ups of tracked interactions. B) Tracking the 




The pore radius profile at different points of the simulation provides another means of 
tracking the transition (Figure 3.5). Snapshots of the trajectory at 0, 2.5, 5, 7.5, and 10 ns 
were saved and the pore radius along the pore axis in each was determined using the 
program HOLE [14]. Over the first 5 ns, we noted a contraction of the inner vestibule, 
presumably as a result of the cytosolic domains being pushed together. During this 
period, the conduction pore radius is never larger than a chloride ion throughout its 
length, demonstrating that the channel is indeed closed when the NBDs are dissociated or 
in the early stages of dimer formation in our simulation. Subsequently, the formation of a 
tight NBD dimer results in conformational changes in the TM region leading to its 
expansion. A through-pore that is continuously larger than a chloride ion develops at 7.5 
ns and is maintained through the end of the simulation, and is characterized by an inner 
vestibule and a large outer vestibule separated by a “narrow region” centered around 
S341 in TM6. Such a pore profile is in agreement with experimental data suggesting the 
existence of a narrow region and anion selectivity filter around S341 [18,19].  
 
Figure 3.5: Pore radius profiles over the course of the simulation 
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Side Chain Interactions 
As the channel opening transition sweeps through the structure, the local 
microenvironment around each residue could change as a result of backbone translation 
and rotation, exposing them to interactions with different neighboring residues over the 
course of the transition. In order to assess a subset of these interactions — those formed 
as a result of electrostatic attraction with basic residues — we analyzed all 104 arginine 
and lysine residues in our models for close contacts with neighboring negatively charged 
(aspartate or glutamate) and hydroxyl-containing (serine, threonine, tyrosine) amino acids 
for salt bridge and hydrogen-bonding interactions (Table 3.1). “Close contacts” were 
defined as being interactions in which atoms of each residue were within 5 Å of each 
other, and each interaction was classified as being closed-state (existing primarily over 
the first half of the channel opening TMD simulation), open-state (existing primarily in 
the latter half), or persistent interactions. Beside the previously established R347-D924 
[20], R352-D993 [6], and R555-T1246 [16] interactions, our simulations also predict the 
existence of 89 additional interactions between residues in different domains that have 
not previously been reported. Interestingly, 86 of the residues involved in these 
interactions have been linked to CF-causing missense and deletion mutations [21]. We 
hypothesize that these interactions may be vital either to stabilizing a particular CFTR 
state or to the overall structural integrity of the protein. 
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Table 3.1: Side-chain interactions over the course of the simulation 
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Experimental Support for the Models 
One of the intraprotein interactions suggested by our modeling effort — which has not 
been indicated in previous models — is a salt bridge between residues R334 and E217 at 
the outer mouth of the pore (Figure 3.6). This salt bridge is seen in our simulations to be 
stable throughout the proposed C0, C1, and C2 closed states, finally breaking after 
approximately 6.3 ns of the simulation have elapsed — following the formation of the 
tight NBD dimer and changes in interactions in the ICLs — during the final transition to 
the open channel O state (Figure 3.4B).  
 
Figure 3.6: Closed-state E217-R334 salt bridge 
 
Figure 3.7: R334C-E217C double mutant 
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To provide experimental confirmation of the closed and open structures, and the 
transitions between the two, we asked whether cysteines engineered at these two 
positions in the double-mutant R334C/E217C-CFTR could be functionally crosslinked. 
Indeed, in silico mutations of positions 334 and 217 to cysteines retain the side chains of 
their amino acids in close proximity (Figure 3.7) We expressed the double mutant 
channels in Xenopus oocytes, and measured macroscopic currents.  
 
 
Figure 3.8: Crosslinking R334C to E217C locks CFTR channels into the closed state. 
(Data collected by Dr. Guiying Cui.) 
 
The traces in (Figure 3.8) show that R334C/E217C-CFTR can repeatedly be activated by 
stimulation of the co-expressed beta2-adrenergic receptor using isoproterenol, without 
substantial decrement in peak current prior to exposure to the crosslinker MTS-2-MTS. 
When the same cell was exposed to MTS-2-MTS in the absence of isoproterenol (Figure 
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3.8A), when most of the channels should be closed, subsequent exposure to isoproterenol 
failed to activate CFTR channels to the same degree as prior to MTS-2-MTS; these 
results are consistent with the notion that R334C and E217C are positioned very near 
each other in the channel closed state. In the lower trace (Figure 3.8B), the cell was 
exposed to MTS-2-MTS in the continuing presence of isoproterenol, which resulted in a 
rapid decrease in current; after washout of isoproterenol and crosslinker, channels could 
not be reactivated by a second exposure to isoproterenol alone. When fully activated 
under physiological conditions, CFTR channels are only open ~40% of the time [22]. The 
loss of macroscopic current in this experiment, then, represents trapping of channels in 
the closed state by the MTS-2-MTS crosslinker. Subsequent exposure to DTT to break 
the disulfide bond(s) enabled activation upon re-application of isoproterenol. In control 
experiments, exposure to MTS-2-MTS did not have similar effects on the single mutants 
R334C-CFTR and E217C-CFTR, with respect to the ability to re-open channels after 
MTS-2-MTS exposure (Figure 3.9). Similarly, exposure of the double mutant to 
monofunctional MTS reagents did not impact the ability to activate CFTR channels upon 
subsequent reapplication of isoproterenol (Figure 3.10). These are consistent with the 
notion that R334 and E217 approach each other closely in the closed state of CFTR and 





Figure 3.9: Effects of 1 mM MTS2-2MTS on R334C-CFTR and E217C-CFTR channels. 
Representative traces (left) and summary data (right) for macroscopic currents measured 
from R334C- (A) and E217C-CFTR (B) by two-electrode voltage clamp. Channels were 
activated by exposure of the oocyte to isoproterenol (ISO). ND96 = control bath solution. 
The bifunctional MTS reagent was not capable of covalently locking closed CFTR 
channels bearing a single cysteine. (Data collected by Dr. Guiying Cui.) 
 
 
Figure 3.10: Effect of monofunctional MTS reagents MTSET+ (ET+) or MTSES− (ES−) 
in the presence of isoproterenol (ISO). ND96 = control bath solution. Neither MTSET+ 




Targeted Molecular Dynamics Simulations 
Recent studies have employed MD simulations to sample the conformational space 
around particular CFTR homology models [5,7,8]. Simulating large-scale conformational 
transitions using conventional MD, however, is unfeasible in typical timescales. In a 
recent study by Furukawa-Hagiya et al. [8], a free MD simulation starting with a 
homology model of the CFTR closed state with MgATP bound in the NBDs did not 
reveal any significant widening of the transmembrane pore over 100 ns. In the present 
study, we used targeted molecular dynamics to generate a trajectory of one possible 
transition pathway between C0-CFTR and O-CFTR. Although the use of a biasing force 
in this technique prevents definite prediction of the true transition pathway, TMD has 
been successfully employed to study several other ABC proteins [23,24] and it can 
provide valuable information about events that may take place during the transition, 
including large-scale motions of backbone structures, and the changing interaction 
partners and surface accessibility of particular residues as the transition progresses. 
It should be noted that, while the pattern of changes in interactions exhibit a general trend 
from the NBDs upward, the vertical position along the pore axis of a particular 
interacting pair in our simulation is not an absolute determinant of the order in which it 
changes. Thus, while the closed-state salt bridge pair R334-E217 is located in the 
extracellular loops — further away from the NBDs than any of the other pairs shown in 
Figure 3.4 — it appears to break at 6.3 ns, before transmembrane R352-D993 salt bridge 
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is formed, indicating that at least partial freeing of the ECLs may be required for the 
helical rotations that lead to the transmembrane pore opening. 
In our simulations the most significant change during the initial stages of the transition 
from C0 (0 ns) involves the translation of the NBDs toward each other and the 
concomitant contraction of the cytoplasmic vestibule below R352, as suggested by Figure 
6. Such an NBD-initiated transition is consistent with the long-standing hypothesis that 
ATP binding at the NBDs initiates channel opening in CFTR [16]. After 2.5 ns, the 
NBDs come into close approach, but the R555-T1246 inter-NBD hydrogen bond has not 
yet formed, and the channel is closed to ion conduction (Figures 4, 5). Of the trajectory 
snapshots analyzed, the NBDs of the 2.5 ns snapshot have the lowest RMSD when 
superimposed onto the NBDs of the recently crystallized TM287/288 bacterial ABC 
transporter [17] which, like CFTR, has asymmetric NBDs containing one degenerate 
nucleotide binding site. This suggests that the 2.5 ns snapshot may approximate the C1 
partial dimer state that CFTR primarily occupies when closed to ion conduction. Halfway 
through the trajectory, we observe a state where the NBDs are close enough for a 
hydrogen bond between R555 and T1246 to form, but the pore radius in the 
transmembrane region still remains too constricted to allow the passage of a chloride ion. 
This configuration may represent the ATP-bound full dimer closed channel transition 
state that CFTR is thought to adopt during its gating cycle (C2) [16]. A thermodynamic 
analysis by Csanády et al. [25] suggested that this transition state contains a high degree 
of conformational strain, and analysis of our simulation trajectory reveals kinks in the 
intracellular loop regions in this state that may contribute to this. Lending further support 
to the 5 ns structure as a model for the C2 closed transition state, we note that known 
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open-state interactions such as the R352-D993 salt bridge have not yet occurred at this 
stage (Figure 3.4B). In the latter half of the simulation, there is an expansion of the 
transmembrane pore region (Figure 3.5), culminating in a through-pore with radius 
continuously greater than that of a chloride ion (Figure 3.2). As the O-CFTR target state 
is approached, the structure contains inner and outer vestibules separated by a (possibly 
selectivity-conferring) narrow region. We note that this narrow, open region persists 
during the entire transition between the C1 and O states in our simulations, despite a 
widening of the pore in the outer vestibule. The stability of this region was demonstrated 
by Liu et al. [26] who showed that the constriction in this region to extracellularly applied 
reagents remains stable over temperatures from 22°C to 37°C, despite major 
conformational changes in the outer vestibule. 
As the only ABC protein known to have channel-like properties, insights into CFTR 
structure are difficult to extract based solely on studies of the crystal structures of one 
state or another in other ABC transporters. Our simulations provide insights into the 
nature of the C1 partial dimer and C2 closed transition state and the large-scale motions 
involved in the transition between these various states. 
Novel Predicted Side-Chain Interactions 
One of the most promising aspects of our simulations is the ability to track the formation 
and dissociation of specific residue pair interactions as the backbone structures are 
transformed between the various channel states, and we report here possible contacts for 
all positively charged (arginine and lysine) residues over the course of the transition 
(Table 3.1). These predictions will guide experiments to further define the structure of 
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this unique and unusual protein, and, in this study, a novel salt bridge between R334 and 
E217 predicted to break during channel opening was confirmed experimentally using 
functional crosslinking (Figure 3.8); this result also helps explain the heretofore unclear 
role of R334 in CFTR function [27-29]. Notably, many of the amino acids that participate 
in these predicted interactions are also involved in CF disease-associated mutations. 
These predictions should offer insight into the structural defects that lead to CFTR 
dysfunction in these mutants, and, ultimately, into mechanisms that could enable their 
correction. 
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CFTR-SPECIFIC SUBSTITUTIONS IN THE NBDS  
AND THEIR EFFECTS ON STRUCTURE AND FUNCTION 
ABSTRACT 
CFTR is the only ABC protein known to function primarily as a channel protein, rather 
than as an alternating access transporter. The question of how it altered its primary 
function, however, remains unsolved. In these studies, we focused our attention on the 
nucleotide-binding domains, searching for substitutions unique to CFTR that may have 
led to gain of channel function. Leveraging the high sequence homology between CFTR 
and its ABC-C homologs in the NBDs, we employed bioinformatics techniques to 
identify particular sites of interest that appear to have been positively selected in the 
CFTR lineage alone. Comparative molecular modeling and simulations of CFTR and 
Sav1866 NBDs based on the partial dimer template of the TM287/288 crystal structure 
revealed that these sites participate in important interactions involved in binding to and 
hydrolyzing ATP, as wells as in transmitting the conformational changes from the NBDs 
to the other domains of the protein. These interactions are significantly altered in CFTR’s 
NBDs, leading to the hypothesis that loss of ATPase function may have contributed to 
gain of channel function in CFTR. These studies provide an important advance in our 




Our studies of CFTR structure through homology modeling and targeted molecular 
dynamics in the previous chapters have provided insight into the structure and function of 
this gated ion channel. We have based these investigations on the homology of CFTR 
with related proteins in the ATP Binding Cassete (ABC) transporter superfamily. As we 
noted earlier, however, CFTR differs in several important ways from the rest of the ABC 
proteins.  
The Structural Basis of Altered Function in CFTR 
Perhaps the most significant difference between the CFTR and the other ABCs lies in its 
primary function as a chloride ion channel. Most other ABC transporters use the energy 
from ATP binding and hydrolysis at their nucleotide binding domains (NBDs) to pump 
substrates into (in the case of importers) or out of (exporters) the cell. How might CFTR 
differ in order to accommodate its altered primary function? 
Membrane-Spanning Domains 
First of all, we may speculate that the transmembrane regions of CFTR and other ABC 
transporters are likely to be very different. Even the most closely related homologs of 
CFTR — the members of the ABC-C subfamily [1] — are involved in the transport of 
large hydrophobic molecules. CFTR, on the other hand, serves as a conduit for the 
passive transit of small anions (chlorides in particular) across the cell membrane. One 
may therefore expect the structure and biochemical nature of the CFTR pore to be 
substantially different from its ABC-C cousins in order to accommodate its very different 
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substrate. Even more importantly, the fact that CFTR functions as a channel rather than 
an alternating-access transporter necessitates the existence of an “open state” that is open 
at both ends of the transmembrane segment of the protein. This feature — antithetical to 
the function of other ABC proteins — is vital for any viable model of CFTR. However, 
since all the homology models of CFTR created so far — including our own O-CFTR 
model described earlier — are based on templates of ABC proteins with distinct inward-
facing and outward-facing states (and no “open” state) no modeling strategy has yet 
successfully yielded a CFTR structure with a truly open pore. This problem is further 
exacerbated by the poor sequence similarity between CFTR and other ABC proteins 
(particularly the ones that have so far been crystallized) in the membrane-spanning 
domains (MSDs), which prevents strong inference of CFTR structure and function in 
these domains based on these templates. While we were successful in our modeling and 
simulation efforts described in the previous chapters — due primarily to the large body of 
experimental data incorporated into our modeling in addition to the controlled nature of 
the simulations conducted — extending our methodology in order to gain insight into the 
differences between CFTR and its related ABC transporters would be highly speculative. 
R-domain 
The R-domain is another anomaly that is unique to CFTR. An analysis by Sebastian et al. 
[2] revealed that the R-domain sequence is not found in any other protein, and most likely 
originated through de novo expression of previously non-coding sequence beginning 
~550–650 million years ago. The R-domain is thought to play an important role in gating 
the CFTR channel through the phosphorylation of conserved serine residues [3], but it 
remains to be seen whether the introduction of this novel domain was a priming mutation 
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for CFTR to evolve channel activity. Studies on the R-domain, however, suffer from the 
fact that it is largely unstructured, leaving researchers without a framework within which 
to propose and investigate mechanistic hypotheses about its function. We did not 
previously include the R-domain in our modeling for this reason, a choice that may be 
further justified by the fact that CFTR variants lacking the R-domain remain largely 
functional [4].  
Nucleotide-Binding Domains 
This leaves the nucleotide binding domains (NBDs) as potential sites for the investigation 
of differences between CFTR and transporter sequence and structure that may potentially 
have led to the acquisition of novel channel function in the former.  
Unlike the other domains, the NBDs of CFTR show relatively high homology with their 
counterparts in related ABC proteins. This is consistent with the role of the NBDs: 
whereas the MSDs must evolve to accommodate the wide range of substrates associated 
with the various members of the ABC family, all of their NBDs must retain the ability to 
1) bind ATP, 2) hydrolyze ATP, and 3) couple the free energy change of ATP binding / 
hydrolysis to the protein’s function as a transporter (or, in the case of CFTR, a channel). 
The invariant nature of these functions may logically be assumed to give rise to similar 
structures and sequence of these domains across all the ABCs, and publication of high-
resolution crystal structures of the NBDs of several ABC transporters [5-13] and of 
NBD1 of CFTR [14-16] have confirmed this expectation.  
Given its very different functional demands, however, one may still expect to see some 
divergence in CFTR sequence and structure, even in the highly conserved NBDs. Firstly, 
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an NBD dimer contains two potential ATP-binding sites, and a full transporter cycle is 
thought to involve binding and hydrolysis at both these sites. While this may indeed be 
required for the energetically demanding task of transporting large molecules against 
their concentration gradients, it seems unnecessarily expensive for the comparatively 
simple task of opening and closing a channel gate in CFTR. Secondly, if CFTR has 
indeed evolved from a defunct exporter [1], it must have incorporated changes that 
allowed it to slow the rate of ATP hydrolysis in order to allow the open channel state to 
persist for a significant span of time. In fact, to this end, CFTR is one of a small subset of 
ABC transporters for which one of the ATP-binding sites (ABS1) is thought to be 
incapable of ATP hydrolysis [17]. Finally, given that the NBDs interact with the 
intracellular loops (ICLs) of CFTR to transmit the conformational wave initiated by NBD 
dimerization / disassociation, it is not unreasonable to ask whether changes at the 
interface between these domains could also have contributed to altered function in CFTR. 
Indeed, we note with emphasis that the most common CF-causing CFTR mutation — 
∆F508 — is the deletion of a residue in NBD1 located at this very transmission interface. 
In other words, if CFTR did indeed evolve from a degraded ABC transporter, then the 
gain of channel activity function could very well be due to loss-of-function mutations in 
the NBDs that led to impaired ATP binding / hydrolysis and altered transmission of the 
ATP-driven power stroke from the NBDs to the ICLs. 
Conserved Motifs in the Nucleotide Binding Domains of ABC Transporters 
While widely varied in the structures and functions of their membrane integral domains, 
the NBDs of all ABC transporters share several common features. In order to understand 
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how changes in these conserved regions may have led to channel function in CFTR, we 
must first familiarize ourselves with some of the more important of these motifs. The 
location of these motifs in CFTR and Sav1866 sequence are indicated in Table 4.1. 
 
Table 4.1: Conserved motifs in NBDs of CFTR and Sav1866 
Motif CFTR ABS1 CFTR ABS2 Sav1866 
Walker A G458 to S466 G1244 to T1252 G374 to T382 
Signature L548 to Q552 L1346 to H1350 L478 to Q482 
Q-Loop C491 to S495 I1289 to V1293 V420 to N424 
X-Loop I539 to G545 F1337 to G1343 T469 to G475 
Walker B L568 to S573 I1366 to E1371 I498 to E5503 




The Walker A motif (also known as the P-loop or phosphate-binding loop) has the 
sequence pattern GXXXXGK(T/S), where X is any residue and the other letters represent 
the usual 1-letter code for amino acids. This motif — first identified in the F1-ATPase 
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[18] — forms a loop that wraps around the triphosphate of an ATP of GTP molecule, 
binding the nucleotide to the protein. Particularly important are the terminal lysine and 
hydroxyl-containing (serine or threonine) residues, which coordinate the γ- and β- 
phosphate groups of the nucleotide. 
LSGGQ / ABC Signature Motif 
The highly conserved and unique-to-ABC signature motif is the defining characteristic of 
ABC transporters. Also called the ‘C-loop’, it contains the important LSGGQ sequence 
responsible for dimer formation in ABC NBDs [19]: the signature motif of NBD2 binds 
to the ATP molecule bound to the Walker A motif of NBD1, and vice-versa. The 
resulting “composite ATP binding site” (ABS) is usually numbered after the NBD 
contributing the Walker motifs (in the case of the example just mentioned, it would be 
designated ABS1). Dimer formation mediated by the signature motif is essential for the 
subsequent dephosphorylation reaction [20]. 
X-loop & Q-loop 
The newly-identified X-loop — located just upstream of the LSGGQ signature motif — 
has the consensus sequence TEVGERG and is found only in ABC exporters (as well as in 
CFTR) [21-23]. The Q-loop is a variable span of 4-5 residues following a highly 
conserved glutamine residue which coordinates the ATP γ-phosphate and magnesium ion 
at the ABS. Large temperature factors associated with this region in various NBD crystal 
structures suggest that this loop is highly flexible.  
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The Q-loop the X-loop are together thought to comprise the primary coupling interface 
between the NBDs and the rest of the protein through interactions with the intracellular 
loops.  
In one model of the transmission mechanism, ATP binding and hydrolysis in the ABS is 
sensed by the Q-loop glutamine which then triggers concerted movements in the Q-loop 
and X-loop [24,25]. These loops, in turn, are coupled to ICLs through which the 
conformational wave is propagated to the rest of the domains of the protein [21,22,26]. 
Walker B 
There is considerable variability in the Walker B motif among ABC proteins, but the 
general consensus is that it comprises a β-strand containing four hydrophobic amino 
acids followed by an aspartate and a glutamate (commonly represented as hhhhDE) 
[18,27]. Mg2+ is often found to be an essential co-factor for ATP binding and hydrolysis 
and, in ABC proteins, and the Walker B aspartate is thought to co-ordinate these ions. 
The glutamate residue at the end of the Walker B sequence acts as a catalytic base for the 
ATP hydrolysis reaction [28-31]. In a subset of ABC transporters — including the ABC-
C subfamily of which CFTR is a member — substitution of the catalytic glutamate to an 
aspartate is thought to impair ATP hydrolysis at one of the ABSs. 
H-loop / Switch Region 
The H-loop contains an important histidine residue that coordinates the γ-phosphate of 
the bound ATP and, in tandem with the Walker B glutamate, forms part of the “catalytic 
dyad” responsible for ATP hydrolysis [8]. The central role of this histidine in organizing 
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the complex network of hydrogen bonding contacts in the active site has led to it being 
termed the “linchpin” of ATP hydrolysis in some ABC transporters [30].  
D-loop 
Closely following the Walker B region, the D-loop has a consensus sequence of SALD. 
Its exact role remains controversial, although it appears to be involved in both in 
communicating between the subunits of an NBD dimer [32] and for coordinating 
attacking water molecules at the ATPase active site [33]. 
In the following, we will investigate structure/function relationships in the NBDs, 
employing bioinformatics, structural modeling and simulation techniques in order to 
understand the differences between CFTR and its related ABC proteins in these important 
domains. 
METHODS 
Relative Divergence Calculations in the NBDs 
In order to identify sites at which CFTR diverges significantly from its ABC homologs, 
we first generated a multiple sequence alignment of human CFTR protein sequence 
against the 11 other human ABC-C proteins. The sequences were retrieved through a 
BLAST search against the RefSeq database (Table 4.2), and a multiple sequence 
alignment was generated using MUSCLE [34]. In order to filter out apparently divergent 
sites that were not conserved within the CFTRs of other related organisms, a multiple 
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sequence alignment of all available CFTR sequences from the vertebrate subphylum was 
also similarly generated. 
 
Table 4.2: Human ABC-C sequences used to calculate relative divergence 
NAME Accession No. 
ABCC7 (CFTR)  NP_000483 / NM_000492 
ABCC1 (MRP1)  NP_004987 / NM_004996 
ABCC2 (MRP2)  NP_000383 / NM_000392 
ABCC3 (MRP3)  NP_003777 / NM_003786 
ABCC4 (MRP4)  NP_005836 / NM_005845 
ABCC5 (MRP5)  NP_005679 / NM_005688 
ABCC6 (MRP6)  NP_001162 / NM_001171 
ABCC8 (SUR1)  NP_000343 / NM_000352 
ABCC9A (SUR2A)  NP_005682 / NM_005691 
ABCC10 (MRP7)  NP_001185863 / NM_001198934 
ABCC11 (MRP8)  NP_115972 / NM_032583 
ABCC12 (MRP9)  NP_150229 / NM_033226 
 
 
Residues in CFTR may diverge from the ABC consensus sequence simply due to 
generally high rates of evolution at that site across all ABCs (if, for instance, the identity 
of a residue at a particular site has little functional consequence). In order to discriminate 
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between sites with generally high mutation rates from those which showed divergence 
particularly in CFTR, we defined the following metric — which we have termed 
“Relative Divergence” — and calculated it for every CFTR residue (numbered k):  
RDk =
Mean pairwise distance between CFTR and other ABC-Cs at site k









n k n k −1( )









• nk is the number of ABC-C sequences with residues aligned to CFTR residue k,  
• rk,i is the identity of the residue in sequence i (i ∈ [1, nk]) aligned to CFTR site k,  
• S(x, y) is a symmetric amino acid substitution function that yields a measure of 
distance (i.e. dissimilarity) between residues x and y, and  
• µ is a pseudocount introduced to normalize the results. 
In our analysis, we used — for S — the Grantham substitution matrix [35], since it 
provides a measure of biochemical dissimilarity and we wanted to highlight residues that 
have evolved away in CFTR to acquire significantly different biochemical properties 
from other ABC transporters. We used a pseudocount µ =10 as this empirically proved to 
normalize our data most effectively. 
 
 87 
Homology Modeling of CFTR NBDs 
In order to model the NBDs of CFTR with its degenerate ATP binding site, we used the 
recently published crystal structure of the bacterial exporter TM287/288 (PDB: 3QF4) 
[32] as a template. The sequence of TM287/288 was extracted from the PDB file and 
added to the sequences used in the analysis above to generate another multiple sequence 
alignment in MUSCLE [34]. The pairwise alignment of TM287/288 and CFTR was 
extracted from the MSA and used as input for homology modeling.  
NBD1 of CFTR contains a unique 32-reside segment (amino acids 404-435) not found in 
other ABCs, often termed the “regulatory insertion”. This segment was modeled using a 
loop search in SYBYL-X (Tripos, Inc.) against its sequence. The remainder of NBD1 and 
NBD2 were separately modeled in Modeller v10 [36] using the alignments generated 
above. 10 models for each NBD were generated and the ones with the lowest molpdf 
scores (a measure of energetic stability and similarity to the template structure [37]) were 
retained. NBD1 (and the regulatory insertion structure) and NBD2 were then assembled 
into a single structure and any clashes were eliminated using an MD simulated annealing 
protocol in Modeller.  
Two separate starting structures were then generated based on the NBD dimer generated 
above: one with MgATP bound only at the degenerate ATP-binding site (CFTR-
ATP/apo), and one with MgATP at both ABSs (CFTR-ATP/ATP). The TM287/288 
template contained only a magnesium ion and adenyl imidodiphosphate (AMP-PNP, a 
non-hydrolyzable ATP analogue) at the degenerate ABS1. The template was first aligned 
to the CFTR model by fitting TM287/288 sequence to CFTR, followed by structural 
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alignment carried out by minimizing RMSD in PyMol (Schrödinger, Inc.). Following this 
alignment, the Mg2+ ion was placed at the same coordinates in the CFTR model as in the 
template, and an ATP molecule was constructed at ABS1 based on the position of the 
AMP-PNP molecule in the template (by replacing the N between the β- and γ-phosphates 
with an O). The second starting structure — with both ABSs occupied — was created 
using the same procedure for ABS1, but then also aligning the crystal structure of CFTR 
NBD1 with bound ATP [14] (PDB: 1R0X) to NBD2 of our model and using the ligand 
coordinates from this structure to construct MgATP at ABS2 of the model. 
Modeling of Sav1866 NBDs 
To contrast with the CFTR structures generated above, we also constructed models of the 
NBDs of the bacterial ABC transporter Sav1866 in a “partial dimer” structure with both 
ABSs occupied (Sav-ATP/ATP). Coordinates of the nucleotide binding domains from the 
crystal structure of Sav1866 in a tight dimer configuration with bound Na+ AMP-PNP (a 
non-hydrolyzable ATP analogue) [38] (PDB: 2ONJ) were first extracted from the rest of 
the protein. The Sav1866 NBDs were then aligned to those in the structure of TM287/288 
[32] (PDB:3QF4) using PyMol (Schrödinger, Inc.). Magnesium ions were substituted for 
the Na+ ions in the structures and the AMP-PNP coordinates were used to construct ATP 
molecules at both ABSs. 
MD Simulations 
In order to guard against the sampling problems inherent in simulations, nine separate 
molecular dynamics simulations of the three starting structures (CFTR-ATP/apo, CFTR-
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ATP/ATP, Sav-ATP/ATP) were carried out, totaling nearly 0.5 µs of total MD 
simulations.  
In every case, the starting system was generated by first converting the protein models to 
all-hydrogen structures (guessing the coordinate of the hydrogen atoms which do not 
appear in the crystal structure based on pre-defined topologies), then solvating in TIP3P 
water boxes with at least 15 Å between the boundary of the box and the proteins. K+ and 
Cl- ions were added to each simulation system in order to neutralize the net charge and 
bring the solution potential to 150 mM. System construction was carried out in VMD 
[39].  
All MD simulations were carried out in NAMD v2.8 [40] using the CHARMM27 force-
field topology definitions and parameters [41]. Steric clashes were first eliminated 
through 50,000 steps of conjugate gradient minimization while holding the protein and 
MgATP restrained through harmonic restraints. A 5 ns MD simulation was then carried 
out — again with protein and MgATP held restrained — to equilibrate the solvent. This 
was followed by nine production runs: two of length 25 ns and one 100 ns-long for each 
of the three systems. All simulations were carried out in NPT (constant temperature / 
constant pressure) conditions using Langevin temperature and pressure controls set at 
310K and 1atm. The SHAKE algorithm [42] was used to fix hydrogen bond lengths, 




Identification of Divergent Sites in CFTR NBD1 
We investigated the differences in the primary structure of CFTR NBDs that may have 
led to the altered function of the protein by analyzing the sequences of human CFTR and 
the other 11 members of its closest relatives in the human ABC-C subfamily [1]. 
In order to tease apart the effects of background mutation (versus positive selection for 
particular traits in CFTR specifically), we computed a metric that we have termed 
Relative Divergence (RD) for each site in CFTR NBD1 (see Methods for more details). 
The rate of evolution at a particular site can be influenced by a variety of factors. If, for 
instance, a particular residue is located in a region of the protein that is not important for 
its function, mutations at that site will be more highly tolerated than in function-critical 
sites across all transporters. On the other hand, sites that are conserved everywhere 
including CFTR may be vitally important for functions common to all ABCs, but would 
not yield any information about the lineage-specific evolution of channel activity. RD 
provides a relatively simple measure — a single number — that contains both these 
overcomes both these pitfalls. Roughly, RD is a measure of the biochemical dissimilarity 
between CFTR and other transporters at a particular residue normalized to the general 
degree of variance across all ABC-Cs at that residue. A high value of RD (> 3) signifies 
that CFTR is significantly different from other ABCCs at a particular site, and that the 
difference is probably not just due to general variability at that position (i.e., it is 
conserved in other ABCCs, but divergent in CFTR). Analysis of sequence divergence in 
the NBDs in this way suggests sites at which positive or directional selection has been at 
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work, possibly due to the acquisition of novel function (channel vs. transporter activity) 
in CFTR.  
The results of RD analysis for NBD1 and NBD2 are shown in Figure 4.1 and Figure 4.2. 
Spikes in the plots represent sites of initial interest, which are then filtered based on 
conservation within CFTRs of different organisms — if a site has high RD when 
comparing human CFTR to other ABC-Cs but is not conserved within CFTRs, it is not 
likely to contribute significantly to CFTR-specific function. 
 
 
Figure 4.1: Relative divergence of CFTR sites in NBD1 
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Figure 4.2: Relative divergence of CFTR sites in NBD2 
 
Focusing on the NBD1 domain that contains the catalytically dead binding site, we note 
the existence of 22 residues with RD > 3. Filtering by conservation within CFTRs leaves 
9 residues of interest — S605, S573, Y577, G544, C491, S489, K536, F626, and T582 —  
that all have the following characteristics: 
• within vertebrate CFTR sequences, these sites are highly conserved 
• equivalent sites in other (non-CFTR) ABC-C transporters are highly conserved 
• equivalent sites in other ABC-C transporters are biochemically different from 
those in CFTR 
 93 
In order to gain a better understanding of the possible mechanisms by which these 
important (and apparently directed) unique-to-CFTR NBD1 substitutions may have led to 
channel activity in CFTR, we conducted a review of existing experimental studies that 
allude to each of these twelve residues. We also noted CF-causing mutations occurring at 
these sites. Table 4.3 summarizes our findings. 







S605 H   The switch region histidine is essential for ATP hydrolysis in other ABC proteins, missing in CFTR. 
S573 D S573C S573F 
The acidic residue at the end of the Walker B sequence (D in other 
ABC-C, E in all other ABCs) is essential for ATP hydrolysis in 
other ABC, missing in CFTR. 
Y577 A Y577E Tyrosine in place of D-loop consensus alanine (SALD) 





This hydrophilic mutation at the NBD1/ICL4 interface may 
weaken/alter NBD/MSD coupling. 
S489 A   This hydrophilic mutation at the NBD1/ICL4 interface may weaken/alter NBD/MSD coupling. 
K536 G K536E Mutation to positively charged residue, possibly near intracellular mouth of pore. 
F626 E/R   
May engage in hydrophobic interactions with the regulatory 
extension(RE) region, and possible binding site for 





This threonine is essential for PKA activation [44] 
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Modeling of the CFTR Partial Dimer State 
Having identified sites in the primary structure that appear to have been under positive 
selective pressure in NBD1 of CFTR, we investigated the functional role of these sites 
through computational modeling and simulations of the CFTR’s NBDs. 
As mentioned earlier, crystal structures of human CFTR NBD1 exist [14,15]. However 
they were crystallized in the absence of the membrane spanning domains. Furthermore, 
they were crystallized with bound ATP or non-hydrolyzable ATP analogues, and are thus 
likely to be different from the structure of CFTR NBDs in the closed channel in their 
native environments where they interact extensively with the intracellular loops of the 
MSDs. In previous chapters, we used the structure of murine P-glycoprotein to model the 
structure of the closed channel state of CFTR. This has proven adequate as a starting 
point and yielded a number of fruitful hypotheses about the structure of the closed state, 
but — as we addressed in our prior discussions — it has been shown that CFTR is 
unlikely to adopt this completely dissociated structure for most of its gating cycle [17]. In 
particular, it is thought that one of CFTR’s two ATP binding sites (ABS1) is not 
functionally competent; it is capable of binding ATP but not hydrolyzing it. As a result, 
the NBD dimer is thought to remain in close contact at this site and the majority of the 
conformational movement that results in channel gating is thought to occur due to 
binding, dimerization, hydrolysis and dissociation at the functional ABS2 site.  
The recent publication of the crystal structure of a TM287/288 [32] — a bacterial 
transporter which, like CFTR, has a degenerate ABS in NBD1 — opens up the possibility 
of a more accurate analysis of the “partial dimer” state of CFTR. This protein was 
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crystallized with bound nucleotide at the degenerate binding site but without any ATP in 
the competent ABS2. Homology modeling of CFTR NBDs based on the NBDs of this 
template therefore yielded what we believe to be the most accurate picture yet of the 
partial dimer structure of CFTR’s NBDs (henceforth CFTR-ATP/apo) (Figure 4.3, left). 
An additional structure with ATP at both binding sites (CFTR-ATP/ATP) (Figure 4.3, 
center) was also created in order to study the dynamics of the NBDs upon ATP binding at 
the functional site. 
Modeling of Sav1866 Partial Dimer State 
In order to investigate the differences between the NBDs of CFTR and those of an ABC 
transporter with two canonical binding sites, we also created a partial dimer structure of 
the bacterial ABC exporter Sav1866. The NBDs from the crystal structure of Sav1866 
with the non-hydrolyzable ATP analogue AMP-PNP bound at both ABSs [38] (PDB: 
2ONJ), were aligned to the NBDs from the TM287/288 partial dimer crystal structure 
[32] to generate a model of the partial-dimer Sav1866 state (Sav1866-ATP/ATP) (Figure 
4.3, right). Both the CFTR models and the Sav1866 model were used as starting 
structures for subsequence molecular dynamics simulations. 
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Figure 4.3: Modeled NBD systems in ribbon representation. 
 
Locations of CFTR-specific Subsititions 
Mapping the nine residues of interest identified from our earlier bioinformatics analysis 
onto our molecular model of the CFTR NBD1 (Figure 4.4) reveals that these unique-to-
CFTR substitutions may be classified into four clusters depending on their location in the 
NBD structure (and, therefore, the most likely mode by which they influence CFTR 
function). 
1. Substitutions at the ATP-binding sites: S573, and S605. These likely alter ATP 
binding and hydrolysis and thus affect channel gating. (Orange in Figure 4.4.) 
2. Substitutions at the interface between the two NBDs and between motifs within the 
NBDs: G544, Y577. These may alter dimer formation and thus affect gating. (Red.) 
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3. Substitutions at the NBD-ICL interface: S489, C491. These may impact the 
transduction of the conformational wave from the NBDs to the MSDs through the 
ICLs. (Green.) 
4. Substitutions at the peripheral surfaces of the NBDs: K536, T582, F626. These sites 
may be involved in interactions with the R-domain of CFTR, regulate CFTR activity 
directly as sites of phosphorylation, or otherwise be involved in maintaining the 









Figure 4.4: Front and top (rotated 90 degrees about the horizontal axis) views of CFTR 
NBD1 showing locations of CFTR-specific substitutions. ATP molecule shown in stick 
representation. 
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MD Simulations of Modeled NBDs 
All-atom, unbiased MD simulations were carried out on all three starting systems: CFTR-
ATP, CFTR-ATP/ATP and Sav1866-ATP. For each of these, three simulations were 
carried out: two lasting 25 ns each, and one that was extended to 100 ns, resulting in a 
total of nine simulations and a total simulated time of 0.45 µs. 
Analysis of total RMSD (Figure 4.5) for all the simulations revealed that, in all cases, the 
majority of the conformational change occurred in the first 20 ns of the every simulation. 
Extending the simulation out to 100 ns showed very little change in any of the structures 
by either visual inspection of the trajectory or by analysis of the RMSD plots. The final 
structures from each of the simulations were also remarkably consistent, particularly at 
the ABSs and the NBD interfaces where we were most interested. Differences in the final 
RMSDs values between different runs of the same system can be attributed primarily to 
slightly different organizations of motifs in the periphery of the NBDs. Note that the RI 
loop — which was modeled de novo (since no equivalent segment existed in the available 
crystal structures) — was omitted from the RMSD plots. 
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Figure 4.5: RMSD evolution and snapshots of A) CFTR-ATP/ATP, B) CFTR-ATP/apo, 
and C) Sav1866-ATP/ATP systems. RMSD was measured for protein heavy atoms 
except those in the regulatory insertion loop of CFTR models. 
 
ATP and the Canonical Signature Motif are Required for Tight NBD Dimerization  
In order to investigate whether our CFTR models were capable of forming tight dimers 
despite having only one functional ABS, and whether ATP binding was necessary for 
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dimer formation, we observed the trajectories of both the CFTR-ATP/apo and CFTR-
ATP/ATP systems over 100 ns. In both cases, we note a nearly immediate collapse of the 
NBD dimers into more compact configurations, suggesting that our CFTR homology 
models based on the TM287/288 crystal structure were not minimum energy structures. 
Following this initial compaction, however, the two systems behaved differently. 
Whereas the ATP/ATP structure continued to close the inter-dimer gap present in the 
initial “partial dimer configuration”, the ATP/apo structure remained partially open at the 
apo binding site. As a measure of inter-NBD separation, we plotted the distance between 
the C-α atoms of the terminal hydroxyl-containing residue in the Walker A motif (T465 
in ABS1, S1251 in ABS2) and the second glycine in the signature motif (G1349 in 
ABS1, G551 in ABS2) (Figure 4.6, top). The inter-NBD distance at both these points at 
25 ns is maintained throughout the remainder of the 100 ns simulations (Figure 4.6, 
bottom-left). In both cases, the separation is greater for the CFTR-ATP/apo system, 
although this difference is more pronounced in the ABS2 site, which contains ATP in one 
of the simulations but is empty in the other. Notably, ATP binding at the competent 
binding site results in tighter binding than at the degenerate ABS1. Since dimer formation 
is generally considered a prerequisite for enzymatic hydrolysis in ATP NBDs, this 
observation may partly explain why ABS1 is catalytically dead. 
We note that the inter-NBD distance dips quickly in the ATP/apo simulation and then 
rebounds slightly at around the 15 ns mark. From visual inspection of the trajectory, we 
note that this is approximately the point at which the regulatory insertion loop on NBD1 
docks onto the periphery of NBD2 in our simulation. However, due to the speculative 
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nature of the RI structure in our model, it is not possible to say whether this feature of our 
simulations has biological relevance. 
For comparison, we also inspected the inter-NBD distance for our Sav1866-ATP/ATP 
model as over 100 ns. As in our CFTR simulations, the Sav-based model the initial 
partial dimer structure of the Sav1866 also underwent a transition to a tight dimer. 
Plotting the distance between the equivalent sites to those mapped for the CFTR models 
(S381 and G481 of the opposing NBD) (Figure 4.6, bottom-right), we note that the 
transition was completed within the first 20 ns. The final separation of the ABS2 site 
(functional in both CFTR and Sav1866) was nearly identical in our Sav1866 and CFTR-
ATP/ATP simulations, indicating that this site in CFTR is in fact capable of forming a 
canonical tight dimer in the presence of ATP. At the ABS1 site, on the other hand, we 
observe a marked difference between the final separation in CFTR (where this site is 
degenerate) and Sav1866 (where it is canonical).  
Taken together, these results confirm the hypothesis that ATP acts as a molecular “glue” 
that binds the two NBD dimers together. Upon closer inspection of the final structures 
produced in our simulations, we note that each ATP molecule interacts through a network 
of non-covalent interactions with the Walker A motif of one NBD monomer and the 
LSGGQ signature residues of the opposing monomer (Figure 4.7, top). Mutation of the 
of signature motif to LSHGH at CFTR’s non-canonical binding site weakens this inter-




    








Figure 4.7: Close-up of ATP-binding site 1 in Sav1866 (top) and CFTR (bottom). 
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CFTR D-loop Substitutions Stabilize the NBD1 Q-Loop Glutamine Q493 
The tyrosine residue at site 577 in CFTR is located in the so-called D-loop of NBD1 and 
is equivalent to an alanine residue in all other ABC-C’s as well as in Sav1866 (the second 
residue of the canonical SALD motif). In our simulations, this tyrosine forms strong 
hydrogen bonds with the highly conserved catalytic glutamine Q493 in the so-called “Q-
loop” of NBD1 (Figure 4.8). This glutamine, in turn, coordinates with both the Mg2+ and 
the γ-phosphate in the non-canonical ABS1. Interestingly, the counterpart residue of 
Y577 in NBD2 — H1375 — is also divergent from the NBD consensus (alanine) and 
participates in another Q-loop-stabilizing hydrogen bond with Q493. The Q-loop is 
thought to be a primary mediator of conformational signaling between the NBDs and the 
ICLs in CFTR [24] and other ABC transporters [25,45].  
 
Figure 4.8: D-loop residues stabilize Q-loop glutamine in CFTR but not in Sav1866. 
Hydrogen bonds represented as dashed lines. ATP and Mg2+ bound to ABS1 are also 
shown in these figures. (Snapshots at t = 100 ns.) 
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G544 Replaces a Salt Bridge Between the X-loop and Q-loop in CFTR 
G544 was also identified in our analysis to be a unique-to-CFTR substitution; the 
equivalent site in most other ABC-Cs and Sav1866 is a basic arginine or lysine. In our 
simulations of Sav1866, the equivalent X-loop site (R474) forms a salt bridge with a Q-
loop aspartate (D423) that couples these two motifs. The Q-loop and the X-loop together 
form a major part of the NBD-ICL coupling interface, and their concerted motion may be 
necessary transmitting the ATP-driven conformation wave from the NBDs to the rest of 
the protein [25,26,45]. However, since the associated ABS in CFTR is catalytically 
inactive, the G544 X-loop substitutions may serve to decouple this interface from events 
at the degenerate binding site. 
 
Figure 4.9: The Q-loop and X-loop of Sav1866 are coupled by a salt bridge in Sav1866, 




CFTR is the only known member of the ABC superfamily known to have channel 
activity. In this study, we identified sites within the nucleotide binding domains of CFTR 
that appear to have undergone lineage-specific positive evolutionary selection, and 
investigated their possible functional roles — particularly with regard to the acquisition 
of channel function — through molecular modeling and simulations. 
By defining a measure of Relative Divergence we were able to identify sites that are 
highly conserved in other ABC transporters, but divergent in CFTR — and therefore 
likely candidates for understanding the emergence of channel behavior. Many such sites 
were identified (Figure 4.1 and Figure 4.2), but in the present analysis we focused 
primarily on the NBD1 sites listed in Table 4.3.  
CFTR-Specific Substitutions Render ABS1 Catalytically Incompetent 
Two substitutions at the ATP-binding site 1 —S573 and S605 — likely affect the 
efficacy of ATP binding and hydrolysis and thus alter the timing of channel closure. The 
serine at site 573 in CFTR occurs at the end of the Walker B sequence, replacing the 
“catalytic carboxylate”-containing aspartate or glutamate amino acid in its ABC 
homologs. This residue was found in several other ABC transporters to be essential for 
the conversion of ATP to ADP, serving as the catalytic base for the hydrolysis reaction 
[28-31]. Similarly, the serine at position 605 is a universally conserved histidine in other 
ABC transporters, also thought to be crucial for coordinating ATP hydrolysis [30]. We 
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surmise that CFTR substitutions away from the ABC consensus at these sites result in 
slowed (or abolished) ATP hydrolysis at ATP-binding site 1. 
Our MD simulations of Sav1866 and CFTR also indicate that dimer formation is never 
complete at the degenerate site, due to substitutions in the LSGGQ signature motif of the 
opposing NBD (LSHGH in CFTR) that significantly reduce the strength of the non-
covalent interactions between the bound ATP molecule and the opposing NBD monomer 
(Figure 4.7). Since dimer formation is known to be essential for ATP hydrolysis in ABC 
NBDs, these substitutions are likely to further impair nucleotide dephosphorylation in the 
degenerate site. 
Interestingly, this loss of ATPase function may have led to gain of channel function in 
CFTR. Impaired dephosphorylation of bound ATP at the degenerate site allows the NBD 
dimer to remain in close contact over prolonged periods relative to other ABC 
transporters, thus increasing channel open time. In addition, if the NBDs are never 
completely dissociated, ATP turnover at the functional ABS2 may be sensed more 
rapidly, resulting in faster tight dimer formation and increasing the efficiency of channel 
gating.  
CFTR-Specific Substitutions Alter Inter-Domain Communication Pathways 
Previous studies on ATP binding and hydrolysis in the NBDs of Sav1866 and other ABC 
transporters reveal the central role of the Q-loop [22,45,46]. This loop has a single highly 
conserved glutamine that coordinates the MgATP at the ABS. Amino acids immediately 
downstream from this glutamine, however, are highly variable, and the structure of the Q-
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loop has been shown to be alternately extended and retracted in several NBD crystal 
structures [10,12,47,48]. It has been suggested that the Q-loop glutamine binds to the 
Mg2+ and / or γ-phosphate at the active site. Upon hydrolysis, this interaction is broken, 
and the Q-loop undergoes a “switching” transition that induces changes in the secondary 
structure upstream [45]. The Q-loop is also thought to interact strongly with the X-loop 
motif, participating in collective motions upon the release of MgATP. In turn, both the Q-
loop and the X-loop participate in persistent interactions with the intracellular loops of 
the membrane-spanning domains, and ATP-driven conformational changes in the NBDs 
are thought to be transmitted to the rest of the protein through this interface [24,25,46]. 
This transduction pathway — from the ABS to the Q-loop/X-loop to the ICLs — appears 
to be broken in the case of the degenerate binding site of CFTR in three ways. First, two 
residues — Y577 and H1375 — that deviate from the consensus D-loop SALD sequence 
are seen to interact with the ABS1 Q-loop glutamine (Q493) in our simulations (Figure 
4.8). These interactions may have a stabilizing effect, locking the glutamine in place and 
preventing the Q-loop “switching” observed in other ABC transporters. Secondly, in our 
Sav1866 simulations, we observed close coupling of the Q-loop and the X-loop through a 
salt bridge between D423 and R474 (Figure 4.9), which may be important for 
coordinating the collective motion of these two domains necessary for signal 
transduction. In CFTR, the residues at the equivalent sites are F494 and G544, 
respectively, and no coupling interactions are observed between the Q-loop and the X-
loop in our CFTR simulations. Finally, residues C491 and S489 — located where the 
ICLs are thought to dock into NBD1 — are unique-to-CFTR substitutions that deviate 
significantly from the ABC consensus at equivalent sites (Table 4.3); in both cases, the 
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CFTR variant is significantly more hydrophilic than the consensus residue. We speculate 
that these substitutions will also alter the NBD:ICL interaction in CFTR, although — 
without modeling the rest of the protein — we are not yet able to determine how. 
The question of how CFTR alone —of all the ABC transporters — came to gain channel 
activity is a fascinating one that remains to be answered definitely. In the preceding 
studies, we focused our efforts only on the nucleotide-binding domains of CFTR, asking 
what changes in the many conserved motifs of these subunits could have led lineage-
specific gain-of-function. Due to high homology between CFTR and its ABC-C 
homologs in the NBDs we were able to employ bioinformatics techniques to identify 
particular sites of interest which appear to have been positively selected in the CFTR 
lineage alone. Comparative molecular modeling and simulations of CFTR and Sav1866 
NBDs revealed that these sites participate in important interactions involved in binding to 
and hydrolyzing ATP, as wells as in transmitting the conformational changes from the 
NBDs to the other domains of the protein; interactions which are significantly saltered in 
CFTR’s NBDs. These studies provide an important advance in our understanding of 
CFTR’s role as an ion channel. 
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CONCLUSIONS & FUTURE WORK 
The cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel 
found in the apical membranes of many types of epithelial cells, where it plays a crucial 
role in ion and fluid homeostasis. Defects in CFTR due to mutation underlie cystic 
fibrosis (CF), the most common life-shortening autosomal recessive genetic disease 
among Caucasians. CFTR malfunction is also involved polycystic kidney disease and 
secretory diarrhea due to cholera. There is a tremendous impetus, therefore, to understand 
CFTR at a molecular level. 
Modeling & Simulations of CFTR Gating 
CFTR is a member of the ABC superfamily of proteins, but anomalous in being the only 
member of this ancient family to exhibit channel activity. Nonetheless, it share several 
features in common with its ABC transporter cousins, including the formation of dimers 
between its two intracellular nucleotide binding domains upon ATP binding, which leads 
to a chain of conformation changing events that culminates — in the case of CFTR — in 
opening of the transmembrane channel. 
In order to visualize the conformational changes in the transition from the closed to open 
states and to form hypotheses about the underlying mechanisms, we generated new 
homology models of CFTR in the open and closed states. Our open-state model preserved 
the expected R347–D924 and R352–D993 salt bridges, and presented a greater number of 
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the pore-lining residues on transmembrane helices TM6 and TM12 in their 
experimentally predicted positions compared to previous CFTR models. Our model 
structures also revealed a possible basis for the observed state-dependent accessibility of 
residue R334 at the extracellular mouth of the pore.  
Furthermore, we performed targeted molecular dynamics simulations between our 
closed- and open-state models in order to generate a trajectory of the conformational 
transitions that may occur in a channel opening event. By tracking the formation and 
breakage of particular interactions in the nucleotide-binding domains, the intra-cellular 
loops, and the membrane-spanning domains over the course of the trajectory, we found 
that our simulations demonstrated a conformational wave that was initiated at the 
nucleotide-binding domains (NBDs) and ended with the formation of an open conduction 
pathway in the transmembrane pore, consistent with the notion that ATP-binding at the 
NBDs drives channel opening in CFTR. Analysis of our simulation trajectory also 
revealed intermediate structures that likely represent the molecular conformation of 
CFTR at several stages of its gating cycle, including a closed state that bears close 
resemblance to the partial-dimer crystal structure of the related ABC transporter 
TM287/288, and a strained transition state with fully dimerized NBDs but with a channel 
pore that is closed to chloride conduction. Changes in side-chain interactions that were 
unconstrained in our modeling were also observed in all major domains of the protein, 
and the predictive value of our models was confirmed through experimental validation of 
one such novel intra-protein salt bridge (R334–E217) that breaks near the end of the 
channel opening transition. 
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Future Work 
Even though our models have been verified to some extent, they remain only models. 
With the expected advent of new crystal structures with greater homology to CFTR — 
and perhaps a crystal structure of CFTR itself — we believe that there remains room for 
more the creation of more accurate models. Our use of restraint-based modeling also 
leaves the door open for the introduction of additional empirically derived constraints as 
more structure/function data becomes available. We chose to use a biased simulation 
protocol — targeted molecular dynamics — for computational expediency. The use of 
more efficient conformational sampling algorithms, and the advent of faster, and cheaper 
computer hardware could soon allow simulations of the entire CFTR protein in its native 
environment that capture biologically relevant motions without the need for applying any 
external forces. 
Identification of CFTR-Specific Substitutions and Their Effects 
CFTR is the only ABC protein known to function primarily as a channel protein, rather 
than as an alternating access transporter. In order to begin understanding the molecular 
basis for this altered function, we focused our attention on the nucleotide-binding 
domains, searching for substitutions which are unique to CFTR. Leveraging high 
homology between CFTR and its ABC-C homologs in the NBDs, we employed 
bioinformatics techniques to identify particular sites of interest that appear to have been 
positively selected in the CFTR lineage, but are largely conserved elsewhere. 
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Subsequently, we applied molecular modeling techniques to create models of CFTR and 
Sav1866 NBDs based on the partial dimer template of the TM287/288 crystal structure, 
and subjected them to unbiased molecular dynamics simulations in the presence and 
absence of ATP in their binding sites. Mapping the CFTR-specific substitutions sites onto 
these models revealed that several of them participate in important interactions involved 
in binding to and hydrolyzing ATP. Whereas the Walker A motif for binding ATP was 
conserved at both ATP-binding sites, there are several CFTR-specific substitutions in the 
catalytic residues in the switch region and Walker B sequence, as well as the signature 
motif required for dimer formation, of ABS1. Substitutions are also seen which appear to 
abolish coupling of the Q-loop associated with ABS1 to its ICL interface, potentially 
altering the transmission of the conformational changes from the NBDs to the other 
domains of the protein. The fact that these substitutions are unique to CFTR and so is 
channel activity leads to the hypothesis that loss of ATPase function may have 
contributed to gain of channel function in CFTR.  
Future Work 
Having identified sites in the NBDs that are substantially divergent in CFTR, we may 
begin mutating them back to their ABC-C consensus residues to ask if CFTR channel 
activity can be abolished (or, perhaps, if transporter activity can be regained) by reverting 
changes in the NBDs unique to the CFTR lineage. Conversely, we may ask if 
introduction of CFTR-specific substitutions to a closely related transporter, e.g. ABC-C4, 
can diminish its transporter activity (and perhaps even lead to channel formation). 
Ancestral sequence reconstruction methods may also be employed to determine the 
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nature of the earliest common ancestors of CFTR and its closest ABC homologs, in order 
to ask which specific changes may have led to the emergence of channel function. In our 
modeling and simulation, we focused only on the NBDs due to their high homology and, 
therefore, reliable sequence alignments with related ABC-transporters. It may be 
interesting to extend these efforts to include the ICLs and even the membrane spanning 
domains in order to gain a better mechanistic understanding of how CFTR-specific 
substitutions led to altered function. 
 
 
